The Monthly Survey of Manufacturing (MSM) publishes statistical series for manufacturers – sales of goods manufactured, inventories, unfilled orders and new orders. The values of these characteristics represent current monthly estimates of the more complete Annual Survey of Manufactures and Logging (ASML) data.

The MSM is a sample survey of approximately 10,500 Canadian manufacturing establishments, which are categorized into over 220 industries. Industries are classified according to the 2007 North American Industrial Classification System (NAICS). Seasonally adjusted series are available for the main aggregates.

An establishment comprises the smallest manufacturing unit capable of reporting the variables of interest. Data collected by the MSM provides a current ‘snapshot’ of sales of goods manufactured values by the Canadian manufacturing sector, enabling analysis of the state of the Canadian economy, as well as the health of specific industries in the short- to medium-term. The information is used by both private and public sectors including Statistics Canada, federal and provincial governments, business and trade entities, international and domestic non-governmental organizations, consultants, the business press and private citizens. The data are used for analyzing market share, trends, corporate benchmarking, policy analysis, program development, tax policy and trade policy.

1. Sales of goods manufactured

Sales of goods manufactured (formerly shipments of goods manufactured) are defined as the value of goods manufactured by establishments that have been shipped to a customer. Sales of goods manufactured exclude any wholesaling activity, and any revenues from the rental of equipment or the sale of electricity. Note that in practice, some respondents report financial trans­ac­tions rather than payments for work done. Sales of goods manufactured are available by 3-digit NAICS, for Canada and broken down by province.

For the aerospace product and parts, and shipbuilding industries, the value of production is used instead of sales of goods manufactured. This value is calculated by adjusting monthly sales of goods manufactured by the monthly change in inventories of goods / work in process and finished goods manufactured. Inventories of raw materials and components are not included in the calculation since production tries to measure "work done" during the month. This is done in order to reduce distortions caused by the sales of goods manufactured of high value items as completed sales.

2. Inventories

Measurement of component values of inventory is important for economic studies as well as for derivation of production values. Respondents are asked to report their book values (at cost) of raw materials and components, any goods / work in process, and fin­ished goods manufactured inventories separately. In some cases, respondents estimate a total inventory figure, which is allocated on the basis of proportions reported on the ASML. Inventory levels are calculated on a Canada‑wide basis, not by province.

3. Orders

a) Unfilled Orders

Unfilled orders represent a backlog or stock of orders that will generate future sales of goods manufactured assuming that they are not cancelled. As with inventories, unfilled orders and new orders levels are calculated on a Canada‑wide basis, not by province.

The MSM produces estimates for unfilled orders for all industries except for those industries where orders are customarily filled from stocks on hand and order books are not gen­erally maintained. In the case of the aircraft companies, options to purchase are not treated as orders until they are entered into the account­ing system.

b) New Orders

New orders represent current demand for manufactured products. Estimates of new orders are derived from sales of goods manufactured and unfilled orders data. All sales of goods manufactured within a month result from either an order received during the month or at some earlier time. New orders can be calculated as the sum of sales of goods manufactured adjusted for the monthly change in unfilled orders.

4. Non-Durable / Durable goods

a) Non-durable goods industries include:

Food (NAICS 311),
Beverage and Tobacco Products (312),
Textile Mills (313),
Textile Product Mills (314),
Clothing (315),
Leather and Allied Products (316),
Paper (322),
Printing and Related Support Activities (323),
Petroleum and Coal Products (324),
Chemicals (325) and
Plastic and Rubber Products (326).

b) Durable goods industries include:

Wood Products (NAICS 321),
Non-Metallic Mineral Products (327),
Primary Metals (331),
Fabricated Metal Products (332),
Machinery (333),
Computer and Electronic Products (334),
Electrical Equipment, Appliance and Components (335),
Transportation Equipment (336),
Furniture and Related Products (337) and
Miscellaneous Manufacturing (339). 

Survey design and methodology

Beginning with the August 1999 reference month, the Monthly Survey of Manufacturing (MSM) underwent an extensive redesign.

Concept Review

In 1998, it was decided that before any redesign work could begin the basic concepts and definitions of the program would be confirmed.

This was done in two ways: First, a review of user requirements was initiated. This involved revisiting an internal report to ensure that the user requirements from that exercise were being satisfied. As well, another round of internal review with the major users in the National Accounts was undertaken. This was to specifically focus on any data gaps that could be identified.

Secondly, with these gaps or requirements in hand, a survey was conducted in order to ascertain respondent’s ability to report existing and new data. The study was also to confirm that respondents understood the definitions, which were being asked by survey analysts.

The result of the concept review was a reduction of the number of questions for the survey from sixteen to seven. Most of the questions that were dropped had to do with the reporting of sales of goods manufactured for work that was partially completed.

In 2007, the MSM terminology was updated to be Charter of Accounts (COA) compliant. With the August 2007 reference month release the MSM has harmonized its concepts to the ASML. The variable formerly called “Shipments” is now called “Sales of goods manufactured”. As well, minor modifications were made to the inventory component names. The definitions have not been modified nor has the information collected from the survey.

Methodology

The latest sample design incorporates the 2007 North American Industrial Classification Standard (NAICS). Stratification is done by province with equal quality requirements for each province. Large size units are selected with certainty and small units are selected with a probability based on the desired quality of the estimate within a cell.

The estimation system generates estimates using the NAICS. The estimates will also continue to be reconciled to the ASML. Provincial estimates for all variables will be produced. A measure of quality (CV) will also be produced.

Components of the Survey Design

Target Population and Sampling Frame

Statistics Canada’s business register provides the sampling frame for the MSM. The target population for the MSM consists of all statistical establishments on the business register that are classified to the manufacturing sector (by NAICS). The sampling frame for the MSM is determined from the target population after subtracting establishments that represent the bottom 5% of the total manufacturing sales of goods manufactured estimate for each province. These establishments were excluded from the frame so that the sample size could be reduced without significantly affecting quality.

The Sample

The MSM sample is a probability sample comprised of approximately 10,500 establishments. A new sample was chosen in the autumn of 2006, followed by a six-month parallel run (from reference month September 2006 to reference month February 2007). The refreshed sample officially became the new sample of the MSM effective in January 2007.

This marks the first process of refreshing the MSM sample since 2002. The objective of the process is to keep the sample frame as fresh and up-to date as possible. All establishments in the sample are refreshed to take into account changes in their value of sales of goods manufactured, the removal of dead units from the sample and some small units are rotated out of the GST-based portion of the sample, while others are rotated into the sample.

Prior to selection, the sampling frame is subdivided into industry-province cells. For the most part, NAICS codes were used. Depending upon the number of establishments within each cell, further subdivisions were made to group similar sized establishments’ together (called stratum). An establishment’s size was based on its most recently available annual sales of goods manufactured or sales value. 

Each industry by province cell has a ‘take-all’ stratum composed of establishments sampled each month with certainty. This ‘take-all’ stratum is composed of establishments that are the largest statistical enterprises, and have the largest impact on estimates within a particular industry by province cell. These large statistical enterprises comprise 45% of the national manufacturing sales of goods manufactured estimates.

Each industry by province cell can have at most three ‘take-some’ strata. Not all establishments within these stratums need to be sampled with certainty. A random sample is drawn from the remaining strata. The responses from these sampled establishments are weighted according to the inverse of their probability of selection. In cells with take-some portion, a minimum sample of 10 was imposed to increase stability.

The take-none portion of the sample is now estimated from administrative data and as a result, 100% of the sample universe is covered. Estimation of the take-none portion also improved efficiency as a larger take-none portion was delineated and the sample could be used more efficiently on the smaller sampled portion of the frame.

Data Collection

Only a subset of the sample establishments is sent out for data collection. For the remaining units, information from administrative data files is used as a source for deriving sales of goods manufactured data. For those establishments that are surveyed, data collection, data capture, preliminary edit and follow-up of non-respondents are all performed in Statistics Canada regional offices. Sampled establishments are contacted by mail or telephone according to the preference of the respondent. Data capture and preliminary editing are performed simultaneously to ensure the validity of the data.

In some cases, combined reports are received from enterprises or companies with more than one establishment in the sample where respondents prefer not to provide individual establishment reports. Businesses, which do not report or whose reports contain errors, are followed up immediately.

Use of Administrative Data

Managing response burden is an ongoing challenge for Statistics Canada. In an attempt to alleviate response burden, especially for small businesses, Statistics Canada has been investigating various alternatives to survey taking. Administrative data files are a rich source of information for business data and Statistics Canada is working at mining this rich data source to its full potential. As such, effective the August 2004 reference month, the MSM reduced the number of simple establishments in the sample that are surveyed directly and instead, derives sales of goods manufactured data for these establishments from Goods and Services Tax (GST) files using a statistical model. The model accounts for the difference between sales of goods manufactured (reported to MSM) and sales (reported for GST purposes) as well as the time lag between the reference period of the survey and the reference period of the GST file.

In conjunction with the most recent sample, effective January 2007, approximately 2,500 simple establishments were selected to represent the GST portion of the sample.

Inventories and unfilled orders estimates for establishments where sales of goods manufactured are GST-based are derived using the MSM’s imputation system. The imputation system applies to the previous month values, the month-to-month and year-to-year changes in similar firms which are surveyed. With the most recent sample, the eligibility rules for GST-based establishments were refined to have more GST-based establishments in industries that typically carry fewer inventories. This way the impact of the GST-based establishments which require the estimation of inventories, will be kept to a minimum.

Detailed information on the methodology used for modelling sales of goods manufactured from administrative data sources can be found in the ‘Monthly Survey of Manufacturing: Use of Administrative Data’ (Catalogue no. 31-533-XIE) document.

Data quality

Statistical Edit and Imputation

Data are analyzed within each industry-province cell. Extreme values are listed for inspection by the magnitude of the deviation from average behavior. Respondents are contacted to verify extreme values. Records that fail statistical edits are considered outliers and are not used for imputation.

Values are imputed for the non-responses, for establishments that do not report or only partially complete the survey form. A number of imputation methods are used depending on the variable requiring treatment. Methods include using industry-province cell trends, historical responses, or reference to the ASML. Following imputation, the MSM staff performs a final verification of the responses that have been imputed.

Revisions

In conjunction with preliminary estimates for the current month, estimates for the previous three months are revised to account for any late returns. Data are revised when late responses are received or if an incorrect response was recorded earlier.

Estimation

Estimates are produced based on returns from a sample of manufacturing establishments in combination with administrative data for a portion of the smallest establishments. The survey sample includes 100% coverage of the large manufacturing establishments in each industry by province, plus partial coverage of the medium and small-sized firms. Combined reports from multi-unit companies are pro-rated among their establishments and adjustments for progress billings reflect revenues received for work done on large item contracts. Approximately 2,500 of the sampled medium and small-sized establishments are not sent questionnaires, but instead their sales of goods manufactured are derived by using revenue from the GST files. The portion not represented through sampling – the take-none portion - consist of establishments below specified thresholds in each province and industry. Sub-totals for this portion are also derived based on their revenues.

Industry values of sales of goods manufactured, inventories and unfilled orders are estimated by first weighting the survey responses, the values derived from the GST files and the imputations by the number of establishments each represents. The weighted estimates are then summed with the take-none portion. While sales of goods manufactured estimates are produced by province, no geographical detail is compiled for inventories and orders since many firms cannot report book values of these items monthly.

Benchmarking

Up to and including 2003, the MSM was benchmarked to the Annual Survey of Manufactures and Logging (ASML). Benchmarking was the regular review of the MSM estimates in the context of the annual data provided by the ASML. Benchmarking re-aligned the annualized level of the MSM based on the latest verified annual data provided by the ASML.

Significant research by Statistics Canada in 2006 to 2007 was completed on whether the benchmark process should be maintained. The conclusion was that benchmarking of the MSM estimates to the ASML should be discontinued. With the refreshing of the MSM sample in 2007, it was determined that benchmarking would no longer be required (retroactive to 2004) because the MSM now accurately represented 100% of the sample universe. Data confrontation will continue between MSM and ASML to resolve potential discrepancies. 

As of the January 2007 reference month, a new sample was introduced. It is standard practice that every few years the sample is refreshed to ensure that the survey frame is up to date with births, deaths and other changes in the population. The refreshed sample is linked at the detailed level to prevent data breaks and to ensure the continuity of time series. It is designed to be more representative of the manufacturing industry at both the national and provincial levels.

Data confrontation and reconciliation

Each year, during the period when the Annual Survey of Manufactures and Logging section set their annual estimates, the MSM section works with the ASML section to confront and reconcile significant differences in values between the fiscal ASML and the annual MSM at the strata and industry level.

The purpose of this exercise of data reconciliation is to highlight and resolve significant differences between the two surveys and to assist in minimizing the differences in the micro-data between the MSM and the ASML.

Sampling and Non-sampling Errors

The statistics in this publication are estimates derived from a sample survey and, as such, can be subject to errors. The following material is provided to assist the reader in the interpretation of the estimates published.

Estimates derived from a sample survey are subject to a number of different kinds of errors. These errors can be broken down into two major types: sampling and non-sampling.

1. Sampling Errors

Sampling errors are an inherent risk of sample surveys. They result from the difference between the value of a variable if it is randomly sampled and its value if a census is taken (or the average of all possible random values). These errors are present because observations are made only on a sample and not on the entire population.

The sampling error depends on factors such as the size of the sample, variability in the population, sampling design and method of estimation. For example, for a given sample size, the sampling error will depend on the stratification procedure employed, allocation of the sample, choice of the sampling units and method of selection. (Further, even for the same sampling design, we can make different calculations to arrive at the most efficient estimation procedure.) The most important feature of probability sampling is that the sampling error can be measured from the sample itself.

2. Non-sampling Errors

Non-sampling errors result from a systematic flaw in the structure of the data-collection procedure or design of any or all variables examined. They create a difference between the value of a variable obtained by sampling or census methods and the variable’s true value. These errors are present whether a sample or a complete census of the population is taken. Non-sampling errors can be attributed to one or more of the following sources:

a) Coverage error: This error can result from incomplete listing and inadequate coverage of the population of interest.

b) Data response error: This error may be due to questionnaire design, the characteristics of a question, inability or unwillingness of the respondent to provide correct information, misinterpretation of the questions or definitional problems.

c) Non-response error: Some respondents may refuse to answer questions, some may be unable to respond, and others may be too late in responding. Data for the non-responding units can be imputed using the data from responding units or some earlier data on the non-responding units if available.

The extent of error due to imputation is usually unknown and is very much dependent on any characteristic differences between the respondent group and the non-respondent group in the survey. This error generally decreases with increases in the response rate and attempts are therefore made to obtain as high a response rate as possible.

d) Processing error: These errors may occur at various stages of processing such as coding, data entry, verification, editing, weighting, and tabulation, etc. Non-sampling errors are difficult to measure. More important, non-sampling errors require control at the level at which their presence does not impair the use and interpretation of the results.

Measures have been undertaken to minimize the non-sampling errors. For example, units have been defined in a most precise manner and the most up-to-date listings have been used. Questionnaires have been carefully designed to minimize different interpretations. As well, detailed acceptance testing has been carried out for the different stages of editing and processing and every possible effort has been made to reduce the non-response rate as well as the response burden.

Measures of Sampling and Non-sampling Errors

1. Sampling Error Measures

The sample used in this survey is one of a large number of all possible samples of the same size that could have been selected using the same sample design under the same general conditions. If it was possible that each one of these samples could be surveyed under essentially the same conditions, with an estimate calculated from each sample, it would be expected that the sample estimates would differ from each other.

The average estimate derived from all these possible sample estimates is termed the expected value. The expected value can also be expressed as the value that would be obtained if a census enumeration were taken under identical conditions of collection and processing. An estimate calculated from a sample survey is said to be precise if it is near the expected value.

Sample estimates may differ from this expected value of the estimates. However, since the estimate is based on a probability sample, the variability of the sample estimate with respect to its expected value can be measured. The variance of an estimate is a measure of the precision of the sample estimate and is defined as the average, over all possible samples, of the squared difference of the estimate from its expected value.

The standard error is a measure of precision in absolute terms. The coefficient of variation (CV), defined as the standard error divided by the sample estimate, is a measure of precision in relative terms. For comparison purposes, one may more readily compare the sampling error of one estimate to the sampling error of another estimate by using the coefficient of variation.

In this publication, the coefficient of variation is used to measure the sampling error of the estimates. However, since the coefficient of variation published for this survey is calculated from the responses of individual units, it also measures some non-sampling error.

The formula used to calculate the published coefficients of variation (CV) in Table 1 is:

CV(X) = S(X)/X

where X denotes the estimate and S(X) denotes the standard error of X.

In this publication, the coefficient of variation is expressed as a percentage.

Confidence intervals can be constructed around the estimate using the estimate and the coefficient of variation. Thus, for our sample, it is possible to state with a given level of confidence that the expected value will fall within the confidence interval constructed around the estimate. For example, if an estimate of $12,000,000 has a coefficient of variation of 10%, the standard error will be $1,200,000 or the estimate multiplied by the coefficient of variation. It can then be stated with 68% confidence that the expected value will fall within the interval whose length equals the standard deviation about the estimate, i.e., between $10,800,000 and $13,200,000. Alternatively, it can be stated with 95% confidence that the expected value will fall within the interval whose length equals two standard deviations about the estimate, i.e., between $9,600,000 and $14,400,000.

Text table 1 contains the national level CVs, expressed as a percentage, for all manufacturing for the MSM characteristics. For CVs at other aggregate levels, contact the Dissemination and Frame Services Section at (613) 951-9497, toll free: 1-866-873-8789 or by e-mail at manufact@statcan.gc.ca.

Text table 1
National Level CVs by Characteristic

Month	Sales of goods manufactured %	Raw materials and components inventories %	Goods / work in process inventories %	Finished goods manufactured inventories %	Unfilled Orders %
June 2010	0.82	1.13	1.6	1.44	1.30
July 2010	0.77	1.16	1.63	1.44	1.41
August 2010	0.79	1.17	1.59	1.45	1.44
September 2010	0.77	1.21	1.58	1.40	1.58
October 2010	0.79	1.18	1.60	1.45	1.72
November 2010	0.84	1.16	1.62	1.44	1.72
December 2010	0.75	1.19	1.62	1.42	1.70
January 2011	0.80	1.20	1.68	1.35	1.68
February 2011	0.74	1.22	1.72	1.38	1.93
March 2011	0.74	1.21	1.66	1.33	2.77
April 2011	0.76	1.20	1.73	1.32	2.70
May 2011	0.77	1.20	1.71	1.40	2.66
June 2011	0.77	1.17	1.77	1.46	2.70

2. Non-sampling Error Measures

The exact population value is aimed at or desired by both a sample survey as well as a census. We say the estimate is accurate if it is near this value. Although this value is desired, we cannot assume that the exact value of every unit in the population or sample can be obtained and processed without error. Any difference between the expected value and the exact population value is termed the bias. Systematic biases in the data cannot be measured by the probability measures of sampling error as previously described. The accuracy of a survey estimate is determined by the joint effect of sampling and non-sampling errors.

Three sources of non-sampling error in the MSM are non-response error, imputation error and the error due to editing. To assist users in evaluating these errors, weighted rates that are related to these three types of error are given in Text table 2. The following is an example of what is meant by a weighted rate. A cell with a sample of 20 units in which five respond for a particular month would have a response rate of 25%. If these five reporting units represented $8 million out of a total estimate of $10 million, the weighted response rate would be 80%.

The definitions of the three weighted rates noted in Text table 2 follow. The weighted response rate is the proportion of a characteristic’s total estimate that is based upon reported data (excluding data that has been edited). The weighted imputation rate is the proportion of a characteristic’s total estimate that is based upon imputed data. The weighted editing rate is the proportion of a characteristic’s total estimate that is based upon data that was edited (edited data may have been originally reported or imputed).

Text table 2 contains the three types of weighted rates for each of the characteristics at the national level for all of manufacturing. In the table, the rates are expressed as percentages.

Text Table 2
National Weighted Rates by Source and Characteristic

Characteristics	Survey Source			Administrative Data Source
	Response	Imputation	Editing	Modeled	Imputation	Editing
	%	%	%	%	%	%
Sales of goods manufactured	83.44	3.50	5.70	6.49	0.57	0.30
Raw materials and components	74.00	10.71	5.99	0.00	9.29	0.01
Goods / work in process	58.67	10.45	23.07	0.00	7.37	0.44
Finished goods manufactured	76.93	6.84	5.56	0.00	10.38	0.29
Unfilled Orders	51.26	1.86	42.15	0.00	3.58	1.16

Joint Interpretation of Measures of Error

The measure of non-response error as well as the coefficient of variation must be considered jointly to have an overview of the quality of the estimates. The lower the coefficient of variation and the higher the weighted response rate, the better will be the published estimate.

Seasonal Adjustment

Economic time series contain the elements essential to the description, explanation and forecasting of the behavior of an economic phenomenon. They are statistical records of the evolution of economic processes through time. In using time series to observe economic activity, economists and statisticians have identified four characteristic behavioral components: the long-term movement or trend, the cycle, the seasonal variations and the irregular fluctuations. These movements are caused by various economic, climatic or institutional factors. The seasonal variations occur periodically on a more or less regular basis over the course of a year. These variations occur as a result of seasonal changes in weather, statutory holidays and other events that occur at fairly regular intervals and thus have a significant impact on the rate of economic activity.

In the interest of accurately interpreting the fundamental evolution of an economic phenomenon and producing forecasts of superior quality, Statistics Canada uses the X12-ARIMA seasonal adjustment method to seasonally adjust its time series. This method minimizes the impact of seasonal variations on the series and essentially consists of adding one year of estimated raw data to the end of the original series before it is seasonally adjusted per se. The estimated data are derived from forecasts using ARIMA (Auto Regressive Integrated Moving Average) models of the Box-Jenkins type.

The X-12 program uses primarily a ratio-to-moving average method. It is used to smooth the modified series and obtain a preliminary estimate of the trend-cycle. It also calculates the ratios of the original series (fitted) to the estimates of the trend-cycle and estimates the seasonal factors from these ratios. The final seasonal factors are produced only after these operations have been repeated several times.

The technique that is used essentially consists of first correcting the initial series for all sorts of undesirable effects, such as the trading-day and the Easter holiday effects, by a module called regARIMA. These effects are then estimated using regression models with ARIMA errors. The series can also be extrapolated for at least one year by using the model. Subsequently, the raw series, pre-adjusted and extrapolated if applicable, is seasonally adjusted by the X-12 method.

The procedures to determine the seasonal factors necessary to calculate the final seasonally adjusted data are executed every month. This approach ensures that the estimated seasonal factors are derived from an unadjusted series that includes all the available information about the series, i.e. the current month's unadjusted data as well as the previous month's revised unadjusted data.

While seasonal adjustment permits a better understanding of the underlying trend-cycle of a series, the seasonally adjusted series still contains an irregular component. Slight month-to-month variations in the seasonally adjusted series may be simple irregular movements. To get a better idea of the underlying trend, users should examine several months of the seasonally adjusted series.

The aggregated Canada level series are now seasonally adjusted directly, meaning that the seasonally adjusted totals are obtained via X-12-ARIMA. Afterwards, these totals are used to reconcile the provincial total series which have been seasonally adjusted individually.

For other aggregated series, indirect seasonal adjustments are used. In other words, their seasonally adjusted totals are derived indirectly by the summation of the individually seasonally adjusted kinds of business.

Trend

A seasonally adjusted series may contain the effects of irregular influences and special circumstances and these can mask the trend. The short term trend shows the underlying direction in seasonally adjusted series by averaging across months, thus smoothing out the effects of irregular influences. The result is a more stable series. The trend for the last month may be, subject to significant revision as values in future months are included in the averaging process.

Real manufacturing sales of goods manufactured, inventories, and orders

Changes in the values of the data reported by the Monthly Survey of Manufacturing (MSM) may be attributable to changes in their prices or to the quantities measured, or both. To study the activity of the manufacturing sector, it is often desirable to separate out the variations due to price changes from those of the quantities produced. This adjustment is known as deflation.

Deflation consists in dividing the values at current prices obtained from the survey by suitable price indexes in order to obtain estimates evaluated at the prices of a previous period, currently the year 2002. The resulting deflated values are said to be “at 2002 prices”. Note that the expression “at current prices” refer to the time the activity took place, not to the present time, nor to the time of compilation.

The deflated MSM estimates reflect the prices that prevailed in 2002. This is called the base year. The year 2002 was chosen as base year since it corresponds to that of the price indexes used in the deflation of the MSM estimates. Using the prices of a base year to measure current activity provides a representative measurement of the current volume of activity with respect to that base year. Current movements in the volume are appropriately reflected in the constant price measures only if the current relative importance of the industries is not very different from that in the base year.

The deflation of the MSM estimates is performed at a very fine industry detail, equivalent to the 6-digit industry classes of the North American Industry Classification System (NAICS). For each industry at this level of detail, the price indexes used are composite indexes which describe the price movements for the various groups of goods produced by that industry.

With very few exceptions the price indexes are weighted averages of the Industrial Product Price Indexes (IPPI). The weights are derived from the annual Canadian Input-Output tables and change from year to year. Since the Input-Output tables only become available with a delay of about two and a half years, the weights used for the most current years are based on the last available Input-Output tables.

The same price index is used to deflate sales of goods manufactured, new orders and unfilled orders of an industry. The weights used in the compilation of this price index are derived from the output tables, evaluated at producer’s prices. Producer prices reflect the prices of the goods at the gate of the manufacturing establishment and exclude such items as transportation charges, taxes on products, etc. The resulting price index for each industry thus reflects the output of the establishments in that industry.

The price indexes used for deflating the goods / work in process and the finished goods manufactured inventories of an industry are moving averages of the price index used for sales of goods manufactured. For goods / work in process inventories, the number of terms in the moving average corresponds to the duration of the production process. The duration is calculated as the average over the previous 48 months of the ratio of end of month goods / work in process inventories to the output of the industry, which is equal to sales of goods manufactured plus the changes in both goods / work in process and finished goods manufactured inventories.

For finished goods manufactured inventories, the number of terms in the moving average reflects the length of time a finished product remains in stock. This number, known as the inventory turnover period, is calculated as the average over the previous 48 months of the ratio of end-of-month finished goods manufactured inventory to sales of goods manufactured.

To deflate raw materials and components inventories, price indexes for raw materials consumption are obtained as weighted averages of the IPPIs. The weights used are derived from the input tables evaluated at purchaser’s prices, i.e. these prices include such elements as wholesaling margins, transportation charges, and taxes on products, etc. The resulting price index thus reflects the cost structure in raw materials and components for each industry.

The raw materials and components inventories are then deflated using a moving average of the price index for raw materials consumption. The number of terms in the moving average corresponds to the rate of consumption of raw materials. This rate is calculated as the average over the previous four years of the ratio of end-of-year raw materials and components inventories to the intermediate inputs of the industry.

Statistics Canada - Producer Prices Division - 2009/2010

This guide is designed to assist you as you complete the 2009/2010 Informatics Professional Services Price Report. If you need more information, please call the Statistics Canada Help Line at the number on the last page of the guide.

The collected information will help us to produce a price index for informatics professional services.

A price index is a statistical measure that summarizes in one number the price change of a set of goods or services from a base period.

Uses of price indexes:

1. Evaluate business performance - compare self with others in the industry
2. Contract escalation - tie value of contract to index to protect the contract against cost increases
3. Measure economic performance - GDP measurement

Section A: Descriptions of business activities

No data is required to be filled out in this section. This section simply contains quick definitions that can be used as a reference while completing the questionnaire.

Section B: Business activity

The Informatics Professional Services Industries covered by this survey are defined using the North American Industry Classification System (NAICS). The NAICS is part of an international framework to allow for the comparison of industrial performance between different countries.

The four industries covered are:

• Software Publishers
• Data Processing, Hosting and Related Services
• Internet Publishing and Broadcasting, and Web Search
• Computer Systems Design and Related Services

In order to help you choose the category that best describes the activity of your business, we include a formal definition of the inclusions and exclusions of each category below. If you require further help on this question, or if you feel that you are part of another NAICS industry, please call our Help line.

Software Publishers

This Canadian industry comprises establishments primarily engaged in publishing computer software, usually for multiple clients and generally referred to as packaged software. Establishments in this industry carry out operations necessary for producing and distributing computer software, such as designing, providing documentation, assisting in installation and providing support services to software purchasers. These establishments may design and publish, or publish only.

Include:

• Computer software publishing (including designing and developing), packaged
• Computer software, all formats, packaged, publishers
• Games, computer software, packaged, publishers
• Publishers, packaged computer software, all formats

Exclude:

• Mass duplication of software;
• Reselling packaged software;
• Publishing software exclusively on the Internet;
• Providing access to software for clients from a central host site;
• Custom designing software to meet the needs of specific users;

Data Processing, Hosting, and Related Services

This Canadian industry comprises establishments primarily engaged in providing hosting or data processing services. Hosting establishments may provide specialized hosting activities, such as web hosting, video and audio streaming services, application hosting, application service provisioning, or may provide general time-share mainframe facilities to clients. Data processing establishments may provide complete processing and preparation of reports from data supplied by the customer; specialized services, such as automated data entry; or they may make data processing resources available to clients on an hourly or time-sharing basis.

Include:

• Application hosting
• Automatic data processing, computer services
• Computer input preparation services
• Computer processing
• Computer processing services
• Computer time, rental
• Computer time-sharing services
• Data entry services
• Data processing services
• Data processing, computer services
• Disk and diskette conversion services
• Input preparation services, computer
• Leasing of computer time
• Microfilm recording and imaging service
• Optical scanning data services
• Rental of computer time
• Service bureaus, computer
• Video and audio streaming services
• Web hosting

Exclude:

• Processing financial transactions;
• Computer facilities management;
• Data keying or keypunch services, text processing or desktop publishing;
• Access to microcomputers and office equipment from a retail location;

Internet Publishing and Broadcasting, and Web Search Portals

This Canadian industry comprises establishments exclusively engaged in publishing and/or broadcasting content on the Internet or operating web sites, known as web search portals, that use a search engine to generate and maintain extensive databases of Internet addresses and content in an easily searchable format. The Internet publishing and broadcasting establishments in this industry provide textual, audio, and/or video content of general or specific interest. These establishments do not provide traditional (non-Internet) versions of the content that they publish or broadcast. Establishments known as web search portals often provide additional Internet services, such as e-mail, connections to other web sites, auctions, news, and other limited content, and serve as a home base for Internet users.

Include:

• Directory publishing, Internet
• Internet book publishing
• Internet broadcasting
• Internet entertainment sites
• Internet game sites
• Internet newspaper publishing
• Internet periodical publishing
• Internet software publishing
• Newspapers, publishing (exclusively on Internet)
• Publishing, maps, street guides and atlases (exclusively on Internet)
• Technical books, publishing (exclusively on Internet)
• Web search portals

Computer Systems Design and Related Services

This Canadian industry comprises establishments primarily engaged in providing expertise in the field of information technologies through one or more activities, such as writing, modifying, testing and supporting software to meet the needs of a particular customer, including the creation of Internet home pages; planning and designing computer systems that integrate hardware, software and communication technologies; on-site management and operation of clients' computer and data processing facilities; providing advice in the field of information technologies; and other professional and technical computer-related services.

Include:

• Application software programming services, custom
• CAD/CAM systems services
• CAE (computer-aided engineering) systems services
• Computer consulting services
• Computer disaster recovery services
• Computer facilities management services
• Computer hardware consulting services
• Computer programming services, custom
• Computer programs or systems software development, custom
• Computer software consulting services
• Computer software programming services, custom
• Computer software systems analysis and design, custom
• Computer systems analysis and design services
• Computer systems design consulting services
• Computer systems integrators
• Computer-aided design (CAD) systems services
• Computer-aided engineering (CAE) systems services
• Data processing facilities management services
• Design and system analysis, computer services (software)
• Facilities management services, computer
• Facilities support services, computer
• Information management system design services, computer
• Internet page design services, custom
• Local area network (LAN) systems integrators
• Management information systems design consulting services
• Office automation, computer systems integration
• Programming services, computer, custom
• Requirements analysis, computer hardware
• Software installation services
• Software programming, custom
• Software systems analysis and design, custom
• Systems analysis and design, computer services (software)
• Systems analysis and design, computer software
• Systems engineering (system integration)
• Systems integration, computer
• Web page developing

Exclude:

• Retailing computer hardware and software and providing support services;
• Publishing packaged software;
• Providing data processing services;

Thank you again for taking the time to complete the questionnaire. If you have any additional questions or comments please don't hesitate to contact 1-877-604-7828 between 8:00am and 23:00pm Mountain Time or mail to:

Statistics Canada,
Operations and Integration Division,
150 Tunney's Pasture Driveway,
Ottawa, Ontario, K1A 0T6

This document is confidential when completed.

Correct pre-printed information, if necessary, using the corresponding boxes below:

• Facility owner (legal name of corporation, company, etc.)
• Facility operator (legal name of corporation, company, etc.)
• Name of drinking water facility
• Last name - owner contact
• First name - owner contact
• Mailing address
• City
• Province / Territory
• Postal code

Please Read Before Completing

This survey is conducted under the authority of the Statistics Act, Revised Statutes of Canada, 1985, Chapter S-19. Completion of this Questionnaire is a legal requirement under this act.

Survey Purpose

This survey collects detailed information concerning the quantity and quality of water processed by facilities that withdraw raw water from the environment and produce potable water for consumption. The applicable facilities range from ones with complex treatment processes to basic groundwater well supplies that provide minimal or no treatment. This data will be used to track the state of stocks of water on a regional basis in Canada and will also be used in the development of environmental accounts and indicators.

Who should complete this questionnaire?

This survey should be completed by persons knowledgeable with the treatment processes, operating costs and water quality data.

Return of Questionnaire

Please return the completed questionnaire within 60 days of receipt using the enclosed envelope. If you are unable to do so, call 1-866-445-4323 to inform us of the expected completion date. You can also fax it at 1-888-883-7999. If you have lost the return envelope or need help, call us at 1-866-445-4323.

Fax or Other Electronic Transmission Disclosure

Statistics Canada advises you that there could be a risk of disclosure during facsimile or other electronic transmission. However, upon receipt, Statistics Canada will provide the guaranteed level of protection afforded all information collected under the authority of the Statistics Act.

Multiple Water Facilities/sources

If there are multiple water facilities/sources associated with the facility identified on the mailing label, complete Sections 1, 2, 3 and 4 of this survey for the combined total of all facilities. Complete Section 5 for the facility that provided the largest portion of water by volume in 2011.

Confidentiality

The Statistics Act protects the confidentiality of information collected by Statistics Canada.

Data-sharing Agreements

To reduce respondent burden, Statistics Canada has entered into data sharing agreements with provincial and territorial statistical agencies and other government organizations, which must keep the data confidential and use them only for statistical purposes.

Information on confidentiality, data-sharing agreements and record linkages can be found on the last page of this questionnaire.

Please complete this questionnaire using a black ballpoint pen.

Person primarily responsible for completing this questionnaire:

• Last name
• First name
• Organization
• Telephone number, Extension
• Fax number
• E-mail address

Section 1 – Drinking Water Plant Information for 2011

Facility for which this questionnaire is completed

1. In 2011, did the facility identified on the mailing label withdraw water from the environment, in order to treat and/or convey potable water to a permanent community of 300 or more people?

• 1. Yes
• 3. No. If no, please complete the cover page and question 1 only, and return the questionnaire in the enclosed envelope. Thank you.

Source/Raw Water Type

Instructions

• Do not write in coloured areas. Comments on any section of this survey should be provided in the space on page 15.

• Indicate the percentage and type of source water (raw water) obtained for processing by this facility below. If there are multiple water facilities/sources associated with the facility identified on the mailing label, complete this part to represent the total for all associated sources.

• Indicate the number of production facilities for each source water type where raw water withdrawn from the environment was treated and/or conveyed as potable water to a distribution system.

	Percentage %	Number of production facilities
2. Surface water
3. Groundwater
4. GUDI - Groundwater Under Direct Influence of surface water

Facility Location and Coordinates

(If the address is the same as the address on page 1, indicate "same")

5. If there are multiple water facilities/sources being reported for the facility identified on the mailing label, enter the location and/or coordinates for the facility that produced the largest volume of potable water in 2011. List the names of other facilities/sources in the comments section on page 15.

• Address number
• Street or road name
• Street type (Rd, Ave, etc.)
• Name of township or municipality
• Postal code
• There is no civic address

If no civic address, answer only one of questions 6, 7 or 8. There are mapping websites and free software, such as Natural Resources Canada's "The Atlas of Canada: Toporama" and "Google Earth" that can assist you in finding coordinates either in decimal degrees, in degrees, minutes, seconds or in Universal Transverse Mercator (UTM).

6. Facility Coordinates (decimal degrees)

• Latitude:
• Longitude:

7. Facility Coordinates (degrees, minutes, seconds)

• Latitude:
• Longitude:

8. Facility Coordinates (Universal Transverse Mercator – UTM zone, eastings and northings)

• Zone:
• Eastings:
• Northings:

Plant Capacity

Instructions

Capacity for 2011 is to be reported in the units used at the drinking water facility. If there are multiple water facilities/sourcesbeing reported for the facility identified on the mailing label, report the combined total for all associated sources.

9. What was the maximum rated treatment capacity of this facility in 2011? (Specify the units in question 10.)

10. Select the unit on the left and the time period on the right for the capacity value in question 9.

Unit

• 1 Cubic metres
• 2 Litres
• 3 Mega Litres (1 million litres)
• 4 Imperial gallons (1 imperial gallon = 4.5 litres)
• 5 U.S. gallons (1 U.S. gallon = 3.8 litres)
• 6 Other (specify units clearly):

Time Period

• 1 Per second
• 2 Per minute
• 3 Per day
• 4 Per year
• 5 Other (specify):

11. How many days in 2011 did the facility operate at greater than 90% capacity?

Sector Use and Population Served

Instructions

Report the percentage of water used by the sectors identified and the population served for the facility identified on themailing label. If there are multiple water facilities/sources being reported for the facility identified on the mailing label, reportthe combined total for all associated sources.

12. Of the total potable water produced, indicate the percentage consumed by each category below. If unknown, please check the "Do not know" box.

• Do not know. Go to question 14

	Percentage %
Residential
Industrial, commercial, institutional and other non-residential
Losses from the distribution system
Wholesale water provided to other jurisdictions
Total	100

13. What sources of information were used for the sector use percentages? Mark all that apply.

1. Specific study/analysis for this facility
2. Water billing accounts
3. Other (specify):

14. What was the size of the population served by this Drinking Water Plant in 2011?

1. Persons
2. Residences/connections
3. Other (specify):

15. What sources of information were used for the size of the population served? Mark all that apply.

1. Specific study/analysis for this facility
2. Water billing accounts
3. Census data
4. Other (specify):

Section 2 – Potable Water Volumes for 2011

Instructions

16. Report by month below the volumes of potable water produced by this drinking water facility. If there are multiple water facilities/sources being reported for the facility identified on the mailing label, report the combined total for all associated sources.

17. Monthly potable water volumes for 2011 are to be reported in the units used at the drinking water facility. Select theunit of measure (right column) for the volumes produced (left column) for all volumes reported in this section.

	Volumes
January
February
March
April
May
June
July
August
September
October
November
December
Total

Unit

1. Cubic metres
2. Litres
3. Mega Litres (1 million litres)
4. Imperial gallons (1 imperial gallon = 4.5 litres)
5. U.S. gallons (1 U.S. gallon = 3.8 litres)
6. Other (specify units clearly):

18. Are potable water volumes metered or estimated?

1. Metered
2. Estimated

Section3 – Water Treatment Processes For 2011

Instructions

In this section, report the treatment processes applied to the raw/source water in 2011. Note: disinfection only (e.g. chlorination) is a treatment process.

19. Are there multiple water facilities that withdraw raw water directly from the environment being reported for the facility identified on the mailing label?

• Yes. Go to question 20
• No. Go to question 22

20. Does each facility use the same water treatment process?

• Yes. Go to question 22
• No. Go to question 21

21. For the facility that produced the largest volume of potable water, indicate what percentage of the total volume it represents:

• Go to question 22 and respond for the facility that produced the largest volume ofpotable water.

22. Is the raw water withdrawn by this facility conveyed directly without treatment as potable water for consumption?

Note: disinfection only (e.g. chlorination) is a treatment process.

• Yes. Go to question 63
• No. Complete questions 23 to 62

Instructions

In the "Process Used" column, confirm either yes or no to all the water treatment processes listed below.

Either Yes or No must bechecked for each line. Reviewthe entire list prior to makingselections.

Unit Processes for Water Treatment	Process Used
	Yes	No
Pre-treatment
23. Microscreening
24. Other pre-treatment (specify):
Disinfection/Oxidation
25. Chlorination (hypochlorites or chlorine gas)
26. Chlorine dioxide
27. Chloramination
28. UV irradiation
29. Ozonation
30. Application of potassium permanganate		(Indicate "no" if only used to recharge a greensand filtration system.)
31. Other disinfection/oxidation reagents
Chemical Treatment or Addition
32. Fluoridation (if 'yes', mark all those applied)	(If 'yes', mark all those applied. 1 Sodium fluoride 2 Sodium silicofluoride 3 Hydro-fluosilicic acid 4 Ammonium silicofluoride)
33. Alkalinity adjustment for process control
34. pH adjustment for process control
35. Corrosion control – pH adjustment
36. Corrosion control – alkalinity adjustment
37. Corrosion control – inhibitors (if 'yes', mark all those applied)	(If 'yes', mark all those applied. 1 Orthophosphates 2 Polyphosphates 3 Silicates 4 Other
Coagulation/Flocculation & Filter Aid
38. Coagulation – aluminum based coagulant
39. Coagulation – ferric based coagulant
40. Other coagulant
41. Enhanced coagulation
42. Flocculation
Clarification/sedimentation
43. Sedimentation – conventional, tube, plate or high rate
44. Dissolved air flotation (DAF) – conventional or high rate
45. Other clarification – (sludge blanket, pulsed blanket, ballasted, solids contact or other)
Filtration
46. Filtration – granular media (single, dual or triple media)
47. Granular activated carbon – used as part of filter media
48. Granular activated carbon – used as separate unit process
49. Filtration – membrane (microfiltration)
50. Filtration – membrane (ultrafiltration)
51. Filtration – cartridge/bag
52. Filtration – slow sand
Other Processes
53. Aeration – transfer of oxygen or air to water
54. Air stripping – contacting water with air to transfer contaminants to air
55. Lime softening
56. Activated alumina
57. Ion exchange
58. Sequestering
59. Greensand filtration
60. Powdered activated carbon
61. Reverse osmosis or nano filtration
62. Other processes (specify):

Section 4 – Annual Treatment Costs for 2011 Calendar Year

Capital Expenditures

Instructions

• Report capitalized costs for 2011 in Canadian dollars for the calendar year (January-December). If there are multiple water facilities/sources being reported for the facility identified on the mailing label, report the combined total for all associated sources.

• Provide capital costs related to the acquisition and treatment of source/raw water.

• Exclude costs associated with distribution.

• Include money spent to add, expand or upgrade physical assets such as:

  • property
  • buildings
  • machinery
  • processing equipment/infrastructure

• Include capitalized costs related to waste treatment processes (i.e. backwash/sludge processing and residuals disposal related to potable water production)

• Include construction and engineering costs such as:

  • installation
  • retrofitting
  • contingencies
  • contractor
  • engineering
  • legal and related administrative fees

• Include indirect costs related to capital expenditures such as:

  • housing
  • permitting
  • land
  • training
  • piloting
  • education

63. 2011 Capital expenditures: $ Millions, Thousands, Hundreds

Operation and Maintenance Costs

Instructions

• Provide Operation and Maintenance (O&M) costs for 2011 related to the acquisition and treatment of source/raw water. If there are multiple water facilities/sources being reported for the facility identified on the mailing label, report the combined total for all associated sources.

• Exclude costs associated with distribution.

• Include the following:

  • materials (chemicals and replacement parts)
  • labour (internal and external staff including laboratory personnel)
  • energy

• Include other costs such as:

  • waste disposal and residuals handling related to potable water production
  • analytical/sampling costs
  • any associated administration and service costs directly related to O&M (consultants, contractors)
  • O&M costs related to waste treatment processes (i.e. backwash/sludge processing and residuals disposal related to potable water production)

64. 2011 O&M Costs

• Materials (chemicals and replacement parts): $ Millions, Thousands, Hundreds
• Labour (internal and external staff): $ Millions, Thousands, Hundreds
• Energy: $ Millions, Thousands, Hundreds
• Other (specify): $ Millions, Thousands, Hundreds
• Total: $ Millions, Thousands, Hundreds

Section 5 – Raw Water Quality Data for 2011

Instructions

• The purpose of this section is the compilation of water quality data comparable to the applicable limits in Provincial/ Territorial and/or Guidelines for Canadian Drinking Water Quality (GCDWQ). Water quality data submitted should be comparable (based on method of testing) to these guidelines where applicable.

• If there are multiple water facilities/sources associated with the facility identified on the mailing label, complete this section for the facility that provides the largest portion of water by volume with available data that reflects the source/raw water quality processed by the facility.

• Provide the number of samples, minimum, maximum, and average values for the parameters identified. If the number of samples is large due to on-line metering, enter 999.

• Enter 0 for the number of samples if the parameter is not monitored.

• For annual data (page 10), if results are not available for 2011, provide results for the most recent year available.

• When calculating an average using low level data (not detected), use 1/2 the Reported Detection Limit (RDL) if there are some values above the RDL. See example below:
  • Sample 1 0.09 mg/L
  • Sample 2 0.07 mg/L
  • Sample 3 <0.06 mg/L (non-detected) {½ RDL = 0.03}
  • Sample 4 <0.04 mg/L (non-detected) {½ RDL = 0.02}
  • Sample 5 <0.06 mg/L (non-detected) {½ RDL = 0.03}
  • Average = (0.09 + 0.07 + 0.03 + 0.02 + 0.03) / 5 = 0.048
  • Maximum = 0.09
  • Minimum = ND

  If all values are not detectable, report the minimum/maximum/average as "ND".

• Report nitrate results as nitrogen. If necessary, consult your laboratory to confirm how nitrate was reported. The conversion factor is: 1 mg/L Nitrate-nitrogen (NO₃^-- N) = 4.43 mg/L Nitrate (NO₃^-).

• Report nitrite results as nitrogen. If necessary, consult your laboratory to confirm how nitrite was reported. The conversion factor is: 1 mg/L Nitrite-nitrogen (NO₂^-- N) = 3.29 mg/L Nitrite (NO₂^-).

• Report each parameter only in the units indicated. Verify if you need to convert from micrograms per litre (μg/L) to milligrams per litre (mg/L).
  • μg/L ÷ 1000 = mg/L
  • 1 μg/L = 0.001 mg/L
  • 10 μg/L = 0.01 mg/L
  • 100 μg/L = 0.1 mg/L

• Select the reporting units for Escherichia coli and Total coliforms results on pages 11 and 12. If reporting presence/ absence results, use the maximum column to report the number of positive samples (the average and minimum columns are not applicable for Presence/Absence results).

Important: Any additional information or comments regarding the water quality data reported in this section should be provided in the comments section on page 15.

65. Report annual values for the parameters listed below in raw water for 2011 or the most recent year available. See instructions on page 9.

Parameter name and units	Number of samples per year	Minimum value per year	Maximum value per year	Average value per year	Sampling Year
Nitrate (as nitrogen) (milligrams per litre of nitrogen, mg/L-N)
Nitrite (as nitrogen) (milligrams per litre of nitrogen, mg/L-N)
Nitrate/Nitrite - Total (as nitrogen) (milligrams per litre of nitrogen, mg/L-N)
Iron (milligrams per litre, mg/L)
Manganese (milligrams per litre, mg/L)
Colour (true colour units, TCU)
Hardness (as CaCO3) (milligrams per litre, mg/L)
Arsenic (milligrams per litre, mg/L)
Fluoride (milligrams per litre, mg/L)
Sodium (milligrams per litre, mg/L)
Dissolved organic carbon (milligrams per litre, mg/L)
Total organic carbon (milligrams per litre, mg/L)
pH (no units)
Alkalinity - Total (as CaCO3) (milligrams per litre, mg/L)

66. Report monthly values for Escherichia coli in raw water for 2011. See instructions on page 9.

Escherichia Coli In Raw Water, 2011

Select units reported:

• Colony forming units per 100 millilitres (cfu/100 mL)
• Most Probable Number per 100 millilitres (MPN/100 mL)
• Presence/Absence (P/A)

Month	Number of samples per month	Minimum value per month (not applicable if reporting P/A)	Maximum value per month (Number of positive samples if reporting P/A)	Average value per month (not applicable if reporting P/A)
January
February
March
April
May
June
July
August
September
October
November
December

67. Report monthly values for total coliforms in raw water for 2011. See instructions on page 9.

Total Coliforms in Raw Water, 2011

Select units reported:

• Colony forming units per 100 millilitres (cfu/100 mL)
• Most Probable Number per 100 millilitres (MPN/100 mL)
• Presence/Absence (P/A)

Month	Number of samples per month	Minimum value per month (not applicable if reporting P/A)	Maximum value per month (Number of positive samples if reporting P/A)	Average value per month (not applicable if reporting P/A)
January
February
March
April
May
June
July
August
September
October
November
December

68. Report monthly values for turbidity of raw water for 2011. See instructions on page 9.

Turbidity Of Raw Water, 2011

Month	Number of samples per month	Minimum value per month	Maximum value per month	Average value per month
		Nephelometric turbidity units (NTU)
January
February
March
April
May
June
July
August
September
October
November
December

69. Report monthly values for temperature of raw water for 2011. See instructions on page 9.

Temperature Of Raw Water, 2011

Month	Number of samples per month	Minimum value per month	Maximum value per month	Average value per month
		degrees Celsius (°C)
January
February
March
April
May
June
July
August
September
October
November
December

Section 6 – Comments

70. Approximately how long did it take to collect the data and complete this survey?

71. We invite your comments on any section of this survey below. Please be assured that we review all comments with the intent of improving the survey.

General Information

Confidentiality

Your answers are confidential.

Statistics Canada is prohibited by law from releasing any information it collects which could identify any person, business, or organization, unless consent has been given by the respondent or as permitted by the Statistics Act, including paragraph 17(2)(g). The confidentiality provisions of the Statistics Act are not affected by either the Access to Information Act or any other legislation. Therefore, for example, the Canada Revenue Agency cannot access identifiable survey records from Statistics Canada.

Information from this survey will be used for statistical purposes only and will be published in aggregate form only.

Data-sharing agreements

To reduce respondent burden, Statistics Canada has entered into data sharing agreements with provincial and territorial statistical agencies and other government organizations, which must keep the data confidential and use them only for statistical purposes. Statistics Canada will only share data from this survey with those organizations that have demonstrated a requirement to use the data.

Section 11 of the Statistics Act provides for the sharing of information with provincial and territorial statistical agencies that meet certain conditions. These agencies must have the legislative authority to collect the same information, on a mandatory basis, and the legislation must provide substantially the same provisions for confidentiality and penalties for disclosure of confidential information as the Statistics Act. Because these agencies have the legal authority to compel businesses to provide the same information, consent is not requested and businesses may not object to the sharing of the data.

For this survey, there is a Section 11 agreement with the provincial and territorial statistical agencies of Newfoundland and Labrador, Nova Scotia, New Brunswick, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, and theYukon.

The shared data will be limited to information pertaining to business establishments located within the jurisdiction of the respective province or territory.

Section 12 of the Statistics Act provides for the sharing of information with federal, provincial or territorial government organizations. Under Section 12, you may refuse to share your information with any of these organizations by writing a letter of objection to the Chief Statistician and returning it with the completed questionnaire. Please specify the organizations with which you do not want to share your data.

For this survey, there are Section 12 agreements with Health Canada, Environment Canada and the statistical agencies of Prince Edward Island, the Northwest Territories and Nunavut.

For agreements with provincial and territorial government organizations, the shared data will be limited to information pertaining to business establishments located within the jurisdiction of the respective province or territory.

Record Linkage

To enhance the data from this survey, Statistics Canada may combine it with information from other surveys or from administrative sources.

Lost the return envelope or need help?

Call us at 1-866-445-4323 or mail to :

Statistics Canada, Operations and Integration Division,
Central Reception, SC0505 Main Building
150 Tunney's Pasture Driveway
Ottawa, Ontario, K1A 0T6

Thank you for completing this questionnaire.

Please retain a copy for your records. Visit our website at www.statcan.gc.ca

Part I – CCR Data Dictionary

Introduction
0.1 Canadian Cancer Registry overview
0.2 CCR system guide document organization
0.3 Part I document organization: CCR Data Dictionary
0.4 Changes to the CCR Data Dictionary for the 2007 and 2008 reference years
0.5 Statistics Canada contacts

Chapter 1 – Reporting Data
1.1 What data should be reported
1.2 How data should be reported
1.3 Typical use cases

Chapter 2 – Data Dictionary
2.0 Introduction
2.1 Input patient variables
2.2 Derived patient variables
2.3 Input tumour variables
2.4 Derived tumour variables

Introduction

• Canadian Cancer Registry overview
• CCR system guide document organization
• Part I document organization – CCR Data Dictionary
• Changes to the Data Dictionary for the 2007 and 2008 reference years
• Statistics Canada contacts

0.1 Canadian Cancer Registry overview

The patient–oriented Canadian Cancer Registry (CCR) evolved from the event–oriented National Cancer Incidence Reporting System (NCIRS). Beginning with cases diagnosed in 1992, incidence figures collected by Provincial and Territorial Cancer Registries (PTCRs) have been reported to the CCR, which is maintained by Statistics Canada. Established as a person–oriented database, the CCR includes mechanisms for updating and clearing death records and is linked to provincial and territorial databases to help track patients across Canada who have been diagnosed with tumours.

0.2 CCR system guide document organization

The CCR System Guide has been separated into three parts to improve access and navigation. Although the three parts are separate, the three documents should be used in conjunction with each other. The different sections of the three–part CCR System Guide often refer to each other. The CCR System Guide is now composed of:

Part I: CCR Data Dictionary provides explanation on the reporting of data, including the scope and detailed information on the input and derived variables.

Part II: CCR Data Loading and Tabulation Master Files provides information on the data loading process, including in–depth descriptions of the various edits performed on the data. Part II also provides information on the Tabulation Master Files, including the scope, content and layout. Part II is followed by several appendices that contain supporting information such as explicit code set tables, guidelines to assist coders and other supportive information.

Part III: CCR Core Reference Tables provides detailed information on the CCR Core Reference Tables such as descriptions of the tables, their usage and any revisions made. Part III is an accompanying document to the "CCR Reference Tables 2009.xls".

0.3 Part I document organization: CCR Data Dictionary

Chapter 1 – Reporting data describes what data that should be reported and how it should be reported to CCR. It also gives some examples of the most common operations for reporting data to CCR.

Chapter 2 – Data dictionary describes all data managed by the system including system–derived variables. For every datum, it also includes a list of related edits that describes the constraints on the datum and the relationship it has with other data.

0.4 Changes to the CCR Data Dictionary for the 2007 and 2008 reference years

Changes to the CCR Data Dictionary for the 2007 and 2008 reference years

Section	Item(s)	Description of change	Effective (reference year)
0	Organization of document	The document has been broken into 3 parts	2008
1.1.2.1	CCRCore Scope	Additional codes to CCR core scope and CCRscope exceptions	2007
1.2	Table 5 Input tumour record file layout	New variables added: T52 – T57	2008
1.2.2	CCR fundamentals	Statements have been updated for clarity: no concept changes	2008
1.2.3.1	Reporting collaborative staging data – typical cases	T52 added to case examples for CCR cooaborative staging scope	2007
1.2.4.1	TNM staging overview	Recurrent tumour prefix 'r' not to be staged or submitted to the CCR	2007
2.1	P6 – Current Surname P7 – First given name P8 – Second given name P9 – Third given name P13 – Birth Surname	Format: Acceptable characters have been specified	2007
2.1	P17 – Underlying cause of death	Description now refers to PD7 – Death clearance underlying cause of death	2007
2.1	P18 – Autopsy confirming cause of death	Description: Reference to an appendix has been added	2007
2.2	PD7 – Death clearance underlying cause of death	Acronym – Acronym has changed	2007
2.2	PD2 – Vital status	The derived variable is now being written only at the Tabulation Master File process	2007
2.2	PD3 – Number of tumours	Description: CCR has adopted seer rules as of 2007	2007
2.2	PD4 – Death clearance cut–off date	Description – Update to description	2007
2.2	PD7 – Death clearance underlying cause of death	Acronym – Acronym has changed	2007
2.3	T5 – Tumour record type	New related edits TVAL53 TVAL54 TVAL55 TVAL56 TVAL57 TCOR26 TCOR27 TCOR29 TCOR30 TCOR31 TCOR32 TCOR33 TCOR34 TCOR35	2008
		New related edits TVAL52 TCOR13	2007
2.3	T6 – Name of place of residence	Format: Acceptable characters have been specified	2007
2.3	T8 – Standard geographic code	Eligible Standard Geographic Codes from 2006 to 2010 now available	2006
2.3	T9 – Census tract	T9 will no longer be loaded onto the CCR. For cases diagnosed in 2006 and onwards, the field should be left blank	2006
2.3	T12 – Date of Diagnosis	New related edits TCOR26 TCOR27	2008
		New references to appendices I and H New related edits TVAL52 TCOR13	2007
2.3	T19 – Laterality	Change to specific values & meaning: Adoption of NAACCR (SEER) laterality codes. Previously loaded data on the CCR database has also been converted to the NAACCR (SEER) laterality code.	2007(AND conversion of previously loaded data 1992–2006)
2.3	T23 – Grade, differentiation or cell indicator	Revision: Application of new guidelines for reporting grade, differentiation, or cell indicator	2006
2.3	T24 – Method used to establish the date of diagnosis	New related edit TCOR13	2006
2.3	T25 – Diagnostic confirmation	New related edit TCOR13	2006
2.3	T27 – CS Tumour Size T28 – CS Extension T29 – CS Tumour size/ext eval T30 – CS lymph nodes T31 – CS reg nodes eval T32 − Regional nodes examined T33 – Regional nodes positive T34 – CS mets at Dx T35 – CS mets eval T36 − CS site specific factor 1 T37 – CS site–specific factor 2 T38 – CS site–specific factor 3 T39 – CS site–specific factor 4 T40 – CS site–specific factor 5 T41 – CS site–specific factor 6	Specific values & meaning: change to meaning of 8 filled and 9–filled fields New related edits (See corresponding sections for additional information)	2007
2.3	T52 – CS Version 1st	New field added	2007
2.3	T53 – Ambiguous Terminology Diagnosis	New field added	2008
2.3	T54 − Date of conclusive diagnosis	New field added	2008
2.3	T55 – Type of multiple tumours reported as one primary	New field added	2008
2.3	T56 – Date of multiple tumours	New field added	2008
2.3	T57 – Multiplicity Counter	New field added	2008
2.4	TD2 – Sequence number	Description: note that CCR has adopted SEER rules as of 2007	2007
2.4	TD5 – Survival interval	Specific values and meanings: The survival interval for DCO records cannot be computed and is recorded as '99998'	2007
2.4	TD19 – CS version latest	CS version latest (formerly TD20) becomes TD19	2007
2.4	TD20 – Filler	TD20 (formerly CS Version latest) becomes a filler	2007

• Please note that changes effective in the 2008 reference year are subject to change.
   
• Additional updates have been made, however only the changes that require action on the part of the PTCRs have been included in this table.
   
• Note that changes effective in the 2006 reference year have also been included here.

0.5 Statistics Canada contacts

PTCRs employees are encouraged to bring forward any questions by contacting one of the following:

Chapter 1 – Reporting data

• What data should be reported
• How data should be reported
• Typical use cases

1.1 What data should be reported

1.1.1 Reported variables

The Canadian Cancer Registry (CCR) system is a patient–oriented database. The following lists of data items must be reported for every patient and every tumour:

Table 1 Reportable data items

Patient

Tumour

Patient reporting province/territory Patient identification number CCR identification number Type of current surname Current surname First given name Second given name Third given name Sex Date of birth Province/territory or country of birth Birth surname Date of death Province/territory or country of death Death registration number Underlying cause of death Autopsy confirming cause of death

Tumour reporting province/territory Tumour patient identification number Tumour reference number CCR identification number Name of place of residence Postal code Standard geographic code Census tract Health insurance number Method of diagnosis Date of diagnosis ICD–9 Cancer code Source Classification flag ICD–O–2/3 Topography ICD–O–2 Histology ICD–O–2 Behaviour Laterality ICD–O–3 Histology ICD–O–3 Behaviour Grade, differentiation or cell indicator Method used to establish the date of diagnosis Diagnostic confirmation Date of transmission CS tumour size CS extension CS tumour size/ext eval CS lymph nodes CS reg nodes eval Regional nodes examined Regional nodes positive CS mets at Dx CS mets eval CS site–specific factor 1 CS site–specific factor 2 CS site–specific factor 3 CS site–specific factor 4 CS site–specific factor 5 CS site–specific factor 6 AJCC clinical T AJCC clinical N AJCC clinical M AJCC pathologic T AJCC pathologic N AJCC pathologic M AJCC clinical TNM stage group AJCC pathologic TNM stage group AJCC TNM stage group AJCC TNM edition number CS Version 1st Ambiguous Terminology Diagnosis Date of conclusive diagnosis Type of multiple tumours reported as one primary Date of multiple tumours Multiplicity counter

For more detail about each variable, see the corresponding section in Chapter 2 – Data dictionary.

1.1.2 Reporting scope

1.1.2.1 CCR core scope

The Canadian Council of Cancer Registries (CCCR) recommends that the following tumours diagnosed in 1992 and onwards be reported to the CCR:

Table 2 CCR core scope

Date of diagnosis	ICD–O–3 Behaviour code	ICD–O–3 Topography codes	ICD–O–3 Histology codes
1992/01/01 to 2006/12/31	1, 2, 3	C00 – C80 except C44 (Skin),	8000 to 9989
	0	C70 – C72 (Meninges, brain and spinal cord, cranial nerves and other parts of central nervous system)	8000 to 9989
2007/01/01 and onwards	0	C70 – C72 (Meninges, brain and spinal cord, cranial nerves and other parts of central nervous system) C75.1, C75.2, C75.3 (pituitary, craniopharyngeal duct and pineal gland)	8000 to 9989
	1 and 3	C00 – C80 except C44 (Skin),	8000 to 9989
	2	C00 – C80 except C44 (Skin), C53 (cervix)C61.9 (Prostate)	8000 to 9989

Table 2.1 CCR Scope Exceptions (not to be reported)

Date of diagnosis	ICD–O–3 Behaviour code	ICD–O–3 Topography codes	ICD–O–3 Histology codes
1992/01/01 and onwards	1, 2, 3	C44 (skin)	8000 to 8005 (NOS) or 8010 to 8046 (epithelial neoplasm) or 8050 to 8084 (squamous cell neoplasm) or 8090 to 8110 (basal cell neoplasm)
2007/01/01 and onwards	2	C53 (cervix), C61.9 (prostate)	All histologies

Notes:

• Tumours with ICD–O–3 Behaviour Codes '6' and '9' must not be reported to the CCR.
• For cases diagnosed in 2007 and onwards, duplicate tumours based on the SEER multiple primary/histology rules must not be reported to CCR.
• For cases diagnosed prior to 2007, duplicate tumours based on the CCR multiple primary rules must not be reported to the CCR. See Appendix D (Part II – CCR Sytem Guide) – multiple primary tumours rules for CCR for more detail.
• Tumours occurring in patients residing outside of Canada must not be reported to CCR. See Appendix T (Part II – CCR Sytem Guide) – Residency guidelines in Canada for more detail.

1.1.2.2 CCR collaborative staging scopeAll tumours within the CCR core scope and diagnosed in 2004 and onwards should be staged according to the Collaborative Staging Manual and Coding Instructions version 01.04.01 (March 25, 2008) available from the Collaborative Staging Task Force of the American Joint Committee on Cancer.

See next section for more details on how to report collaborative staging data.

1.1.2.3 CCR AJCC TNM staging scope

Colorectal, breast and prostate primary tumours diagnosed in 2003 and onwards can be staged according to their corresponding AJCC TNM 6^th Edition staging schema. Reportable tumours are selected based on International Classification of Diseases for Oncology – 3^rd Edition (ICD–O–3) as shown in the following table.

Table 3 CCR AJCC TNM staging scope

Date of diagnosis	Site	ICD–O–3 Topography codes	ICD–O–3 Histology codes	ICD–O–3 Behaviour codes
2003/01/01 and onwards	Colorectal	C18.0 to C18.9; C19.9; C20.9	8000 to 8576; 8935 to 8936; 8940 to 8950; 8980 to 8981	2, 3
	Breast	C50.0 to C50.9	8000 to 8576; 8940 to 8950; 8980 to 8981; 9020	2, 3
	Prostate	C61.9	8000 to 8110; 8120; 8131to 8576; 8940 to 8950; 8980 to 8981	3

See next section for details on how to report AJCC TNM staging data.

1.2 How data should be reported

1.2.1 Input record files

Data must be reported to the Canadian Cancer Registry (CCR) system using flat files encoded with an ISO 8859–1 (Latin 1) compatible character set. Patient data must be reported using the input patient record file and the tumour data must reported using the input tumour record file. See corresponding input record layouts in Table 4 and Table 5 below.

In addition to the specific data items, every input record has a record type and a date of transmission. The record type indicates which action should be conducted by the CCR system (adding, updating or deleting a record in the CCR) while the date of transmission is needed for tracking purposes. For details on a given data item, see its corresponding section in Chapter 2.

Although a data submission (also called a cycle) is normally composed of two files (one input patient record file and one input tumour record file), it may also be composed of only one file for specific needs (for example, updating tumour information only).

Table 4 Input patient record layout

Field	Length	Position	Description	Acronym
P1	2	1 to 2	Patient reporting province/territory	PREPPROV
P2	12	3 to 14	Patient identification number	PPIN
P3	9	15 to 23	CCR identification number	CCR_ID
P4	1	24	Patient record type	PRECTYPE
P5	1	25	Type of current surname	PTYP_CUR
P6	25	26 to 50	Current surname	PCURSNAM
P7	15	51 to 65	First given name	PGNAME_1
P8	15	66 to 80	Second given name	PGNAME_2
P9	7	81 to 87	Third given name	PGNAME_3
P10	1	88	Sex	PSEX
P11	8	89 to 96	Date of birth	PDATBIR
P12	3	97 to 99	Province/territory or country of birth	PPROVBIR
P13	25	100 to 124	Birth surname	PBIRNAM
P14	8	125 to 132	Date of death	PDATDEA
P15	3	133 to 135	Province/territory or country of death	PPROVDEA
P16	6	136 to 141	Death registration number	PDEAREG
P17	4	142 to 145	Underlying cause of death	PCAUSDEA
P18	1	146	Autopsy confirming cause of death	PAUTOPSY
P19	8	147 to 154	Patient date of transmission	PDATTRAN

Table 5 Input tumour record file layout

Field	Length	Position	Description	Acronym
T1	2	1 to 2	Tumour reporting province/territory	TREPPROV
T2	12	3 to 14	Tumour patient identification number	TPIN
T3	9	15 to 23	Tumour reference number	TTRN
T4	9	24 to 32	CCR identification number	CCR_ID
T5	1	33	Tumour record type	TRECTYPE
T6	25	34 to 58	Name of place of residence	TPLACRES
T7	6	59 to 64	Postal code	TPOSTCOD
T8	7	65 to 71	Standard geographic code	TCODPLAC
T9	9	72 to 80	Census tract	TCENTRAC
T10	15	81 to 95	Health insurance number	THIN
T11	1	96	Method of diagnosis	TMETHDIAG
T12	8	97 to 104	Date of diagnosis	TDATDIAG
T13	4	105 to 108	ICD–9 Cancer code	TICD_9
T14	1	109	Source classification flag	TSCF
T15	4	110 to 113	ICD–O–2/3 Topography	TICD_O2T
T16	4	114 to 117	ICD–O–2 Histology	TICD_O2H
T17	1	118	ICD–O–2 Behaviour	TICD_O2B
T18	4	119 to 122	Filler	Not applicable
T19	1	123	Laterality	TLATERAL
T20	1	124	Filler	Not applicable
T21	4	125 to 128	ICD–O–3 Histology	TICD_O3H
T22	1	129	ICD–O–3 Behaviour	TICD_03B
T23	1	130	Grade, differentiation or cell indicator	TGRADE
T24	1	131	Method used to establish the date of diagnosis	TMETHUSED
T25	1	132	Diagnostic confirmation	TMETHCONF
T26	8	133 to 140	Tumour date of transmission	TDATTRAN
T27	3	141 to 143	CS tumour size	TCSTSIZE
T28	2	144 to 145	CS extension	TCSEXTN
T29	1	146	CS tumour size/ext eval	TCSEVAL
T30	2	147 to 148	CS lymph nodes	TCSLNODE
T31	1	149	CS reg nodes eval	TCSRNEVAL
T32	2	150 to 151	Regional nodes examined	TCSRNEXAM
T33	2	152 to 153	Regional nodes positive	TCSRNPOS
T34	2	154 to 155	CS mets at diagnosis	TCSMDIAG
T35	1	156	CS mets evaluation	TCSMEVAL
T36	3	157 to 159	CS site–specific factor 1	TCSSSF1
T37	3	160 to 162	CS site–specific factor 2	TCSSSF2
T38	3	163 to 165	CS site–specific factor 3	TCSSSF3
T39	3	166 to 168	CS site–specific factor 4	TCSSSF4
T40	3	169 to 171	CS site–specific factor 5	TCSSSF5
T41	3	172 to 174	CS site–specific factor 6	TCSSSF6
T42	9	175 to 183	AJCCclinical T	TAJCCCLINT
T43	3	184 to 186	AJCC clinical N	TAJCCCLINN
T44	3	187 to 189	AJCC clinical M	TAJCCCLINM
T45	9	190 to 198	AJCC pathologic T	TAJCCPATHT
T46	6	199 to 204	AJCC pathologic N	TAJCCPATHN
T47	3	205 to 207	AJCC pathologic M	TAJCCPATHM
T48	4	208 to 211	AJCC clinical TNM stage group	TAJCCCLINSG
T49	4	212 to 215	AJCC pathologic TNM stage group	TAJCCPATHSG
T50	4	216 to 219	AJCC TNM stage group	TAJCCSG
T51	2	220 to 221	AJCC TNM edition number	TAJCCEDNUM
T52	6	222 to 227	CS Version 1st	TCSFVER
T53	1	228 to 228	Ambiguous terminology diagnosis	TAMBIGTERM
T54	8	229 to 236	Date of conclusive diagnosis	TDATCONCLUSDIAG
T55	2	237 to 238	Type of multiple tumours reported as one primary	TMULTTUMONEPRIM
T56	8	239 to 246	Date of multiple tumours	TDATMULT
T57	2	247 to 248	Multiplicity counter	TMULTCOUNT

1.2.2 CCR fundamentals

Following is a list of fundamental rules and concepts that may help the Cancer Registries understand the constraints related to data submission to the CCR.

Submission

• Input record files must indicate coherent operations for related patient and tumour records.
• A PTCR can only report data for its jurisdiction.

Ownership

• A Patient record is initially owned by its reporting province/territory. Its ownership may change through the internal record linkage process; if it is found that the same patient is owned by two provinces/territories, sole ownership of the Patient record will be assigned to the province/territory which reported the latest tumour record.
• A Tumour record is always owned by its reporting province/territory. The ownership of a tumour record never changes.
• A PTCR must own a patient or tumour record in order to update or delete it.

Integrity

• Every patient record must be associated with at least one tumour record from the same province/territory.
• Every tumour record must be associated with one patient record.
• The CCR contains only valid and coherent patient and tumour records. Consequently, invalid or incoherent records are rejected by the data editing process. As a temporary measure, invalid staging data (Collaborative Staging and/or AJCC TNM Staging) will not prevent valid core tumour fields from being loaded in the CCR database. In this case, invalid staging data will not be loaded but will be marked as being rejected in the CCR database.

Keys

• The Patient identification number (PIN) must be unique for each patient record from a given province/territory.
• Tumour reference number (TTRN) must be unique for a patient's tumour record from a given province/territory.
• CCR identification number (CCR_ID) connects patient record to its related tumour records from any province/territory.

Scope

• Tumours outside the CCR core scope are not loaded.
• For a given patient record, duplicate tumours based on the CCR multiple primary tumour rules are not loaded.
• Collaborative staging data for tumours outside the CCR collaborative staging scope are not loaded.
• AJCC TNM staging data for tumours outside the CCR AJCC TNM staging scope are not loaded.

1.2.3 Reporting collaborative staging data

1.2.3.1 Typical cases

Case 1: Tumours outside the CCR collaborative staging scope (see section 1.1.2.2)

All corresponding variables (T27 to T41 and T52) must be left blank.

Case 2: Tumours within the CCR collaborative staging scope (see section 1.1.2.2)

• If the tumour has been staged using the collaborative staging schema, then all corresponding variables (T27 to T41 and T52) must be reported according to the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) available from the Collaborative Staging Task Force of the American Joint Committee on Cancer. Unknown variables must be coded using the proper CS schema specific 'Unknown' code.

• If the tumour has not been staged using the collaborative staging schema, then all corresponding variables (T27 to T41 and T52) must be coded using the proper CCR Specific 'Not Staged' code. Variables must not be left blank.

Table 6 CCR Specific 'Not Staged' codes

T27	T28	T29	T30	T31	T32	T33	T34	T35	T36	T37	T38	T39	T40	T41	T52
999	99	9	99	9	99	99	99	9	999	999	999	999	999	999	999999

1.2.4 Reporting AJCC TNM staging data

1.2.4.1 TNM staging overview

The AJCC TNM system is based on the assessment of the T, N, and M components and the assignment of a stage grouping. The structure of TNM varies from site to site. Recurrent tumours (prefix 'r') are not to be staged or submitted to the CCR.

T component

The T element designates the extent of the primary tumour (size or depth of invasion). The numerical subset increases with the progressive extent of the malignant disease. For example:

• Small lesion confined to the organ of origin would be coded as T1;
• Larger tumour size or deeper extension into adjacent structures, tissues, capsules, or ligaments as T2;
• Larger tumour size or extension beyond the organ of origin but confined to the region, T3;
• Massive lesion or one that directly invades another organ or viscera, major nerves, arteries, or bone as T4.

N component

The N component designates the presence or absence and extent of metastasis in the regional lymph nodes.

• In some sites, there is an increasing numerical value based on size, fixation, or capsular invasion.
• In other sites, the numerical value is based on multiple nodal involvement or number and location of the regional lymph nodes.

M component

The M component identifies the presence or absence of distant metastases, including lymph nodes that are not regional.

Stage group

The stage group is assigned using the table listed in the corresponding chapter of the AJCC Cancer staging manual. Stage 0 reflects minimal involvement, usually carcinoma in–situ, whereas Stage IV indicates either greatest tumour involvement or distant metastasis. Histologic grade and age may impact staging in certain sites.

1.2.4.2 Typical cases

Case 1: Tumours outside the CCR AJCC TNM staging scope (see section 1.1.2.3).

All corresponding variables (T42 to T51) must be left blank.

Case 2: Tumours within the CCR AJCC TNM staging scope (see section 1.1.2.3).

• If the tumour has been staged using the AJCC TNM system then all corresponding variables (T42 to T51) must be reported according to the CCR data dictionary corresponding sections. Variables must not be left blank. Unknown variables must be coded using the proper 'Unknown' code.
• If the tumour has not been staged using the AJCC TNM staging system, then all corresponding variables (T42 to T51) must be coded using the proper CCR Specific 'Unknown'/'Not Staged' code (see table below). Variables must not be left blank.

Table 7 CCR Specific 'Unknown' or 'Not Staged' codes

T42	T43	T44	T45	T46	T47	T48	T49	T50	T51
99	99	99	99	99	99	99	99	99	00

1.2.4.3 Data quality

Stage group is "required" for all histology codes listed at the end of the applicable AJCC chapters, including the published (posted) AJCC errata. Cases meeting those requirements must have a clinical stage group (T47) and/or a pathological stage group (T48) and/or TNM stage group (T50) with a valid stage group as defined in the appropriate chapter of the AJCC Cancer staging manual, sixth edition. Unknown stage group will not prevent AJCC TNM staging data from being loaded in the CCR but will be reported through data quality reports.

The following table depicts which ICD–O–3 topography and histology codes require a stage group. All sites included in the following table are also included in the CCR AJCC TNM staging scope.

Table 8 ICD–O–3 Topography and histology codes that require at least one stage group

Site	ICD–O–3 Topography codes	ICD–O–3 Histology codes	ICD–O–3 Behaviour codes
Colorectal	C18.0 to C18.9; C19.9; C20.9	8000 to 8002; 8004 to 8005; 8010; 8012 to 8013; 8020 to 8021; 8032; 8041 to 8045; 8050; 8070; 8140 to 8141; 8210; 8211; 8214 to 8215; 8220 to 8221; 8230; 8261 to 8263; 8480 to 8481; 8490; 8510; 8560; 8570 to 8571; 8935 to 8936	2, 3
Breast	C50.0 to C50.6, C50.8, C50.9	8010, 8020, 8070, 8140, 8200 to 8201, 8211, 8480, 8500 to 8503, 8510, 8520, 8522, 8530, 8540 to 8541, 8543, 8980, 9020	2, 3
Prostate	C61.9	8010, 8041, 8070, 8074, 8082, 8098, 8120, 8140, 8148, 8200, 8260, 8480, 8490, 8500, 8550, 8560	3

Tumours within the CCR AJCC TNM staging scope but not listed in the above table may have unknown stage groups. These cases will not be reported through data quality reports.

1.2.4.4 Technical notes

Extra descriptors
As described on pages 7 and 8 of the AJCC Cancer staging manual, sixth edition, 2 prefixes and 1 suffix are used to identify special cases of TNM or TNM classifications.

Table 9 Descriptors used in AJCC Cancer staging manual, sixth edition

Prefixes		Suffixe
y	Staging is performed during or after treatment (ycTNM or ypTNM)	m	Multiple primary tumours in a single site: pT(m)NM
a	Stage determined at autopsy

These prefixes and suffixes do not affect the stage grouping but they identify pieces of information that require these cases to be analyzed separately. The staging implementation working group decided that the additional descriptors would not be collected in the CCR, as they could not be collected consistently across the country. Therefore, if a registry collects descriptors for an eligible staging record, corresponding variables must be reported without them.

Assigning X

Values	Meaning	Example
TX	Primary Tumour cannot be assessed	When the tumour is identified, but there is not enough information from clinical observation, imaging or microscopic depth of invasion, size, etc. to assign a value. This could also mean that the patient did not return for further workup or treatment.
NX	Regional Lymph nodes have not been or cannot be evaluated	When initial resection takes place, but further workup or treatment is refused, the status of the regional lymph nodes is not available.
MX	Distant metastasis cannot be assessed	When studies have not been performed to adequately assess the presence of metastases.
Clinical or Pathological stage group X	May mean that the case cannot be stage grouped	When there is at least one T, N or M component listed as 'X' but T, N, M components combination does not lead to a stage group.

Prostate cases

If initial diagnosis is through biopsy, and then the patient is put on "watchful waiting" for a period of time, followed by a prostatectomy, then the date of diagnosis should be the date of the biopsy. If the intent of waiting is considered treatment, then the case can only be clinically staged, based on the biopsy information. This initial information can be used for clinical staging information, but there would not be a pathological stage available. This would then be listed with pathologic TNM values of 'X', since the information is not available.

If the intent of the waiting is for surgery, then the information from the prostatectomy can be used for pathologic staging, according to page 5 of the AJCC Cancer staging manual, sixth edition.

1.3 Typical use cases

Adding a new patient and new tumours

• Submit one add patient record and one or more add tumour records.
• Use the same reporting province/territory and patient identification number on both input patient and tumour record to create the relationship.
• Do not provide any CCR identification number.

Adding new tumour(s) to existing patient

• Submit one or more add tumour records.
• Use the reporting province/territory, patient identification number and CCR identification number of the existing patient record in the CCR.

Updating an existing patient

• Submit one update patient record.
• Use the reporting province/territory, patient identification number and CCR identification number of the existing patient record to be updated.

Updating an existing tumour

• Submit one update tumour record.
• Use the reporting province/territory, patient identification number, tumour reference number and CCR identification number of the existing tumour record to be updated.

Deleting an existing patient

• Submit one delete patient record.
• Submit as many delete tumour records as there are tumour records with the same CCR identification number and reporting province/territory in the CCR.
• Use the reporting province/territory, patient identification number and CCR identification number of the existing patient record to be deleted on both delete patient and delete tumour records.
• All remaining fields must be left blank.

Deleting an existing tumour

• Submit one delete tumour record.
• Use the reporting province/territory, patient identification number, tumour reference number and CCR identification number of the existing tumour record to be deleted.
• All remaining fields must be left blank.

Chapter 2 – Data dictionary

• Input patient variables
• Derived patient variables
• Input tumour variables
• Derived tumour variables

2.0 Introduction

2.0.1 Input and derived variable fields

The following describes the various fields in the data dictionary for input patient, derived patient, input tumour and derived tumour variables:

Acronym for a variable name – Input patient variables begin with P and derived patient variables begin with PD. Input tumour variables begin with T and derived tumour variables begin with TD.

Description – A general description of the variable content. Provides additional information such as specific coding instructions; use of the variable; links to other variables; and coding sources.

Effective – Determines the reference years (for example, based on date of diagnosis, not collection date) when the variables are in effect and collected.

Length – The length of the variable in the record layout. Format – Provides formatting details such as data positions and character specifications.

Used by – Field for derived patient and tumour variables only. Provides details about which process reads and/or writes the derived variable.

Specific values & meanings – Lists acceptable values and defines their meanings.

Related edits – Lists edits related to the variable. See Chapter 3 (Part II – CCR System Guide) for more details on the edits.

Revision – Provides historical detail on revisions performed on the variable. The year refers to the reference year (for example, based on date of diagnosis, not collection date).

2.1 Input patient variables

The input patient variables are variables related to the patient and reported by the PTCR. Table 10 lists all the input patient variables and the following pages describe these variables in more detail.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, CCR identification number is described on page P3 – CCR identification number.

Table 10 List of input patient variables

Variable N°	Variable	Acronym
P1	Patient reporting province/territory	PREPPROV
P2	Patient identification number	PPIN
P3	CCR identification number	CCR_ID
P4	Patient record type	PRECTYPE
P5	Type of current surname	PTYP_CUR
P6	Current surname	PCURSNAM
P7	First given name	PGNAME_1
P8	Second given name	PGNAME_2
P9	Third given name	PGNAME_3
P10	Sex	PSEX
P11	Date of birth	PDATBIR
P12	Province/territory or country of birth	PPROVBIR
P13	Birth surname	PBIRNAM
P14	Date of death	PDATDEA
P15	Province/territory or country of death	PPROVDEA
P16	Death registration number	PDEAREG
P17	Underlying cause of death	PCAUSDEA
P18	Autopsy confirming cause of death	PAUTOPSY
P19	Patient date of transmission	PDATTRAN

P1 – Patient reporting province/territory

Acronym: PREPPROV

Description: The Standard Geographic Code (SGC) of the PTCR submitting the patient record to the Canadian Cancer Registry (CCR).

Refer to Appendix T (Part II – CCR System Guide)– Residency guidelines in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 2

Specific values and meaning (P1)

Value	Meaning
10	Newfoundland and Labrador
11	Prince Edward Island
12	Nova Scotia
13	New Brunswick
24	Quebec
35	Ontario
46	Manitoba
47	Saskatchewan
48	Alberta
59	British Columbia
60	Yukon
61	Northwest Territories
62	Nunavut

Related edits: PVAL1, PCOR1, KIM1, KIM3, KIM4, KIM5, KBM1, KBM2, KBM4, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P1)

Year	Description
2004	Related edits changed: See KIM4 and KBM4.
1999	Specific values & meaning: Addition of Nunavut code (62).

P2 – Patient identification number

Acronym: PPIN

Description: The unique identification number assigned by the provincial/territorial registry to each new patient registered.

This field is part of Statistics Canada patient record key. It cannot be updated or reused.

Effective: Reference year 1992 and onwards.

Length: 12

Related edits: PVAL2, PCOR1, KIM1, KIM3, KIM4, KIM5, KBM1, KBM2, KBM4, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P2)

Year	Description
2004	Acronym changed: Formerly known as PIN. Related edits changed: See PVAL2, KIM4 and KBM4.

P3 – CCR identification number

Acronym: CCR_ID

Description: The unique number assigned by Statistics Canada to each new patient at the time of the initial registration in the CCR. 

Effective: Reference year 1992 and onwards.

Length: 9

Format: It is composed of 3 parts:

Position 1–2: Last 2 digits of the year of CCR Processing Date
Position 3–8: Sequential number from 000001–999999.
Position 9: A check digit (See Appendix X (Part II - CCR System Guide) - CCR_ID check digit routine)

Related edits: PVAL3, PCOR1, KBM2, KBM4, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P3)

Year	Description
2004	Related edits changed: See KBM4.

P4 – Patient record type

Acronym: PRECTYPE

Description: The code which identifies the type of record submitted to the CCR.

This field will not be stored or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P4)

Value	Meaning
1	New record
2	Update record
3	Delete record

Related edits: PVAL3, PVAL4, PVAL5, PVAL6, PVAL7, PVAL8, PVAL9, PVAL10, PVAL11, PVAL12, PVAL13, PVAL14, PVAL15, PVAL16, PVAL17, PVAL18, PCOR1, PCOR2, PCOR3, PCOR4, PCOR5, PCOR6, PCOR7, PCOR8, PCOR9, PCOR10, PCOR11, KIM3, KIM4, KIM5, KBM1, KBM2, DIM1, DIM2, DIM3, DIM4, DIM5, PPM1, PPM2.

Revision (P4)

Year	Description
2004	Specific values & meaning: Change of ownership record has been removed. Related edits changed: See PVAL6, PVAL12, PVAL14, PVAL15, PVAL17, PCOR2, PCOR7, PCOR9, PCOR10, PCOR11, KIM4 and KBM4.

P5 – Type of current surname

Acronym: PTYP_CUR

Description: The code describing the type of surname currently used by the patient in field P6 – Current Surname.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P5)

Value	Meaning
0	Current Surname unknown
1	Birth Surname
2	Other type of surname (for example, married name, legal change–of–name)
9	Type of surname unknown

Related edits: PVAL5, PCOR1, PCOR4, PCOR5.

Revision (P6)

Year	Description
Not applicable	Not applicable

P6 – Current surname

Acronym: PCURSNAM

Description: The legal surname currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 25

Format: Acceptable characters are limited to:

• Uppercase letters from ACSII–7 bit character set ([A–Z]);
• Lowercase letters from ACSII–7 bit character set ([a–z]);
• Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü);
• Special characters:
  • Spaces ( );
  • Periods (.);
  • Apostrophes (');
  • Hyphens (–).

Related edits: PVAL6, PCOR1, PCOR4, PCOR5, PCOR6.

Revision (P6)

Year	Description
2007	Format: Acceptable characters are specified.
2004	Description: Current surname contains the value as reported by the PTCR. Standardized current surname is not kept in the CCR anymore.

P7 – First given name

Acronym: PGNAME_1

Description: The first given name (or initial) currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 15

Format: Acceptable characters are limited to:

• Uppercase letters from ACSII–7 bit character set ([A–Z]);
• Lowercase letters from ACSII–7 bit character set ([a–z]);
• Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
• Special characters:
  • Spaces ( );
  • Periods (.);
  • Apostrophes (');
  • Hyphens (–).

Related edits: PVAL7, PCOR1, PCOR2, PCOR3.

Revision (P7)

Year	Description
2007	Format: Acceptable characters are specified.
2004	Description: First given name contains the value as reported by the PTCR. Standardized first given name is not kept in the CCR anymore.

P8 – Second given name

Acronym: PGNAME_2

Description: The second given name (or initial) currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 15

Format: Acceptable characters are limited to:

• Uppercase letters from ACSII–7 bit character set ([A–Z]);
• Lowercase letters from ACSII–7 bit character set ([a–z]);
• Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
• Special characters:
  • Spaces ( );
  • Periods (.);
  • Apostrophes (');
  • Hyphens (–).

Related edits: PVAL8, PCOR1, PCOR2, PCOR3.

Revision (P8)

Year	Description
2007	Format: Acceptable characters are specified.
2004	Description: Second given name contains the value as reported by the PTCR. Standardized second given name is not kept in the CCR anymore.

P9 – Third given name

Acronym: PGNAME_3

Description: The third given name (or initial) currently used by the patient as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 7

Format: Acceptable characters are limited to:

• Uppercase letters from ACSII–7 bit character set ([A–Z]);
• Lowercase letters from ACSII–7 bit character set ([a–z]);
• Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
• Special characters:
  • Spaces ( );
  • Periods (.);
  • Apostrophes (');
  • Hyphens (–).

Related edits: PVAL9, PCOR1, PCOR2, PCOR3

Revision (P9)

Year	Description
2007	Format: Acceptable characters are specified.
2004	Description: Third given name contains the value as reported by the PTCR. Standardized third given name is not kept in the CCR anymore.

P10 – Sex

Acronym: PSEX

Description: The code that represents the sex of the patient.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P10)

Value	Meaning
1	Male
2	Female
9	Sex unknown

Related edits: PVAL10, PCOR1, PCOR2, DIM5.

Revision (P10)

Year	Description
2004	Related edits changed: see PCOR2.

P11 – Date of birth

Acronym: PDATBIR

Description: The patient's date of birth represented by the year, month and day.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (P11)

Value	Meaning
[0000–9998]	Year of birth
9999	Year of birth unknown

MM (P11)

Value	Meaning
[01–12]	Month of birth (January – December)
99	Month of birth unknown

DD (P11)

Value	Meaning
[01–31]	Day of birth
99	Day of birth unknown

Related edits: PVAL11, PVAL12, PCOR1, PCOR7, DIM1.

Revision (P11)

Year	Description
2004	Related edits changed: see PVAL12 and PCOR7.

P12 – Province/territory or country of birth

Acronym: PPROVBIR

Description: The code created by the International Standards Organization¹ (ISO) used to represent the patient's province/territory (if in Canada) or country (if outside Canada) of birth.

The location is coded according to geo–political boundaries at time of birth.

Effective: Reference year 1992 and onwards.

Length: 3

Specific values & meaning (P12)

Value	Meaning
999	Province/territory or country of birth unknown.
[Others]	For Date of birth prior to year 1996, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes prior to 1996. For Date of birth in 1996 and onwards, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes in 1996 and after.

Related edits: PVAL12, PCOR1.

Revision (P12)

Year	Description
2004	Related edits changed: see PVAL12.
1996	Specific values & meaning: new province/territory and country codes list added for date of birth in 1996 and onwards.

P13 – Birth surname

Acronym: PBIRNAM

Description: The legal surname or family/last name under which the patient was registered at birth as reported by PTCR.

Effective: Reference year 1992 and onwards.

Length: 25

Format: Acceptable characters are limited to:

• Uppercase letters from ACSII–7 bit character set ([A–Z]);
• Lowercase letters from ACSII–7 bit character set ([a–z]);
• Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
• Special characters:
  • Spaces ( );
  • Periods (.);
  • Apostrophes (');
  • Hyphens (–).

Related edits: PVAL13, PCOR1, PCOR5, PCOR6

Revision (P13)

Year	Description
2007	Format: Acceptable characters are specified.
2004	Description: Birth surname contains the value as reported by the PTCR. Standardized birth surname is not kept in the CCR anymore.

P14 – Date of death

Acronym: PDATDEA

Description: The patient's date of death represented by the year, month and day.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (P14)

Value	Meaning
0000	Patient is not known to have died
[0001–9998]	Year of death
9999	Year of death unknown

MM (P14)

Value	Meaning
00	Patient is not known to have died
[01–12]	Month of death (January – December)
99	Month of death unknown

DD (P14)

Value	Meaning
00	Patient is not known to have died
[01–31]	Day of death
99	Day of death unknown

Related edits: PVAL14, PVAL15, PVAL17, PCOR1, PCOR7, PCOR8, PCOR10, DIM2, DIM3, DIM4.

Revision (P14)

Year	Description
2004	Related edits changed: See PVAL15, PVAL17 and PCOR7.

P15 – Province/territory or country of death

Acronym: PPROVDEA

Description: The code created by the International Standards Organization² (ISO) used to represent the patient's province/territory (if in Canada) or country (if outside Canada) of death.

The location is coded according to geo–political boundaries at time of death.

Effective: Reference year 1992 and onwards.

Length: 3

Specific values & meaning (P15)

Value	Meaning
000	Patient is not known to have died
999	Province/territory or country of death unknown
[Others]	For Date of death prior to year 1996, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes before 1996. For Date of death in 1996 and onwards, see Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible province/territory or country codes in 1996 and after.

Related edits: PVAL15, PCOR1, PCOR8, PCOR9.

Revision (P15)

Year	Description
2004	Related edits changed: See PVAL15 and PCOR9.
1996	Specific values & meaning: new province/territory and country codes list added for Date of death in 1996 and onwards.

P16 – Death registration number

Acronym: PDEAREG

Description: The registration number found on the official death certificate issued by the Canadian province/territory in which the patient died (see P15 – Province/territory or country of de

Specific values & meaning (P16)

Value	Meaning
000000	Patient is not known to have died
999998	Patient died outside of Canada
999999	Patient died: death registration number is unknown
[Others]	Valid registration numbers

Effective: Reference year 1992 and onwards.

Length: 6

Related edits: PVAL16, PCOR1, PCOR8, PCOR9, PCOR10, PCOR11

Revision (P16)

Year	Description
2004	Related edits changed: See PCOR9, PCOR10 and PCOR11.

P17 – Underlying cause of death

Acronym: PCAUSDEA

Description: The code that represents the patient's underlying cause of death, as determined by the Vital Statistics office from the official death certificate and reported to the CCR by the provincial/territorial Cancer Registry (PTCR).

The underlying cause of death is defined as: 'the disease or injury which initiated the train of morbid events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury'. It is coded using the International Classification of Diseases, 9^th Revision (ICD–9) or International Statistical Classification of Diseases and Related Health Problems, 10^th Revision (ICD-10), depending on the Date of death.

See also PD7 – Death clearance underlying cause of death.

Effective: Reference year 1992 and onwards.

Length: 4

Format: The code must not contain any periods (.).

Specific values & meaning (P17)

Value	Meaning
0000	Patient is not known to have died
0009	Unknown/unavailable underlying cause of death
[Others]	For Date of death prior to year 2000, refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-9 underlying cause of death codes for exact meaning. For Date of death between 2000 and 2002, refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes from 2000 to 2002 for exact meaning. For Date of death in 2003 and onwards, refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes in 2003 and after for exact meaning.

Related edits: PVAL17, PCOR1, PCOR8, PCOR11.

Revision (P17)

Year	Description
2004	Related edits changed: See PVAL17 and PCOR11.
2000	Specific values & meaning: ICD-10 Cause of death codes added.

P18 – Autopsy confirming cause of death

Acronym: PAUTOPSY

Description: The code indicating whether the cause of death from the official death certificate takes account of autopsy findings.

See Appendix I (Part II – CCR System Guide) – Guidelines for abstracting and determining DCO cases for PTCRs in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (P18)

Value	Meaning
0	Patient is not known to have died
1	Autopsy held - results taken into account by the stated cause of death
2	Autopsy held - results not taken into account by the stated cause of death
9	No autopsy/unknown autopsy/do not know if autopsy results have been taken into account by the stated cause of death

Related edits: PVAL18, PCOR1, PCOR8.

Revision (P18)

Year	Description
Not applicable	Not applicable

P19 – Patient date of transmission

Acronym: PDATTRAN

Description: The date on which a copy of the patient record was extracted from the provincial/territorial registry for submission to the CCR.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (P19)

Value	Meaning
[0000-9999]	Year of transmission

MM (P19)

Value	Meaning
[01-12]	Month of transmission (January – December)

DD(P19)

Value	Meaning
[01-31]	Day of transmission

Related edits: PVAL14, PVAL19, PCOR7

Revision (P19)

Year	Description
2004	Acronym changed: Formerly known as PDATTRA2. Related edits changed: See PVAL14 and PCOR7.

2.2 Derived patient variables

The derived patient variables are variables related to the patient and copied/derived/calculated by the CCR system through various processes such as data loading, record linkage, death clearance and tabulation master file creation. Table 11 lists all the derived patient variables; the following pages describe these variables in more detail.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, Vital status is described on page PD2 – Vital status.

Table 11 List of Derived patient variables

Variable N°	Variable	Acronym
PD1	Processing Date – patient record	PDCCRDATPROC
PD2	Vital status	PDCCRVITALST
PD3	Number of tumours	PDCCRNBRTMRS
PD4	Death clearance cut off date	PDDCDATCO
PD5	Death clearance status	PDDCSTAT
PD6	Death clearance method	PDDCMETH
PD7	Death clearance underlying cause of death	PDDCUCD
PD8	Date of death (Un) confirmation	PDDCDATCN

PD1 – Processing date – patient record

Acronym: PDCCRDATPROC

Description: The date of the last action taken against the patient record by Statistics Canada.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (PD1)

Process	Read	Write
Data loading – posting	No	Yes*
Internal record linkage	No	Yes*
Death clearance	No	Yes*
Tabulation master file	Yes	No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (PD1)

Value	Meaning
[0000-9999]	Year of the last action

MM (PD1)

Value	Meaning
[01-12]	Month of the last action (January – December)

DD (PD1)

Value	Meaning
[01-31]	Day of the last action

Revision (PD1)

Year	Description
2004	Acronym changed: Formerly known as PDATPROC.

PD2 – Vital status

Acronym: PDCCRVITALST

Description: The code indicating whether the patient is alive or deceased.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (PD2)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (PD2)

Value	Meaning
1	The patient is not known to have died
2	The patient is deceased

Revision (PD2)

Year	Description
2007	Used by: PD2 is now being written at the Tabulation master file process
2004	Acronym changed: Formerly known as PVITALST

PD3 – Number of tumours

Acronym: PDCCRNBRTMRS

Description: The number of tumour records belonging to the patient record.

Note: The number of tumours may change depending on the Multiple primary rules used (CCR or IARC). As of 2007 the CCR has adopted SEER rules.

Effective: Reference year 1992 and onwards.

Length: 2

Used by (PD3)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (PD3)

Value	Meaning
[1-99]	The number of tumours the patient has at the time of the TMF creation.
**	The Patient has more than 99 tumours at the time of the TMF creation.

Revision (PD3)

Year	Description
2004	Acronym changed: Formerly known as PNBRTMRS.

PD4 – Death clearance cut-off date

Acronym: PDDCDATCO

Description: The date of the latest death event (based on the Canadian Vital Statistics) considered during the death clearance process.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (PD4)

Process	Read	Write
Data loading – posting	No	Yes*
Internal record linkage	No	No
Death clearance	No	Yes*
Tabulation master file	Yes	No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (PD4)

Value	Meaning
0000	Patient never underwent Death clearance.
[0001-9999]	Latest registration year for which the record was matched against the Canadian mortality database.

MM (PD4)

Value	Meaning
00	Patient never underwent Death clearance.
[01-12]	The month of the date described above (January – December).

DD (PD4)

Value	Meaning
00	Patient never underwent Death clearance.
[01-31]	The day of the date described above.

Revision (PD4)

Year	Description
2007	Description: Updated.
2004	Acronym changed: Formerly known as PDCDATCO.

PD5 – Death clearance status

Acronym: PDDCSTAT

Description: The code indicating whether the record has ever participated in Death clearance and its current status with respect to provincial/territorial actions.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (PD5)

Process	Read	Write
Data loading – posting	No	Yes*
Internal record linkage	No	No
Death clearance	No	Yes*
Tabulation master file	Yes	No

* See corresponding section for calculation details.

Specific values & meaning (PD5)

Value	Meaning
0	Patient record never underwent Death clearance
1	Patient record underwent Death clearance - not confirmed as dead
2	Patient record underwent Death clearance - confirmed as dead
3	Patient record no longer confirmed as dead - PTCR has changed the Date of death, province/territory or country of death or Death registration number
4	Patient record no longer confirmed as dead - decision rejected by PTCR

Revision (PD5)

Year	Description
2004	Acronym changed: Formerly known as PDCSTAT

PD6 – Death clearance method

Acronym: PDDCMETH

Description: The code indicating the method used during the Death clearance process to confirm the patient death.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (PD6)

Process	Read	Write
Data loading – posting	No	Yes*
Internal record linkage	No	No
Death clearance	No	Yes*
Tabulation master file	Yes	No

* See corresponding section for calculation details.

Specific values & meaning (PD6)

Value	Meaning
0	Patient never underwent Death clearance or patient not confirmed as dead
1	Match: Identical information on Date of death, province/territory or country of death, Death registration number, sex and date of Birth (year and month only)
2	Probabilistic linkage
3	Inactive default: province/territory reported death information, with no confirmation - record has been inactive for 5 years
4	Age Default: Age > 117 years

Revision (PD6)

Year	Description
2004	Acronym changed: Formerly known as PDCMETHD

PD7 – Death clearance underlying cause of death

Acronym: PDDCUCD

Description: The code reported to Statistics Canada that represents the patient's underlying cause of death, as determined by the Vital Statistics office from the official death certificate.

The underlying cause of death is defined as: 'the disease or injury which initiated the train of morbid events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury'. It is coded using the International Classification of Diseases, 9^th Revision (ICD–9) or International Statistical Classification of Diseases and Related Health Problems, 10^th Revision (ICD–10), depending on the Date of death.

Effective: Reference year 1992 and onwards.

Length: 4

Used by (PD7)

Process	Read	Write
Data loading – posting	No	Yes*
Internal record linkage	No	No
Death clearance	No	Yes*
Tabulation master file	Yes	No

* See corresponding section for calculation details.

Specific values & meaning (PD7)

Value	Meaning
0000	Patient record never underwent Death clearance or not confirmed as deceased. (Default value)
[Others]	For Date of death prior to year 2000, refer to Appendix A (Part III– CCR System Guide) – Core reference tables - Eligible ICD-9 underlying cause of death codes for exact meaning. For Date of death between 2000 and 2002, refer to Appendix A (Part III– CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes from 2000 to 2002 for exact meaning. For Date of death in 2003 and onwards, refer to Appendix A (Part III– CCR System Guide) – Core reference tables - Eligible ICD-10 underlying cause of death codes in 2003 and after for exact meaning.

Revision (PD7)

Year	Description
2008	Acronym changed: Formerly known as PDDCCMDBUCD.
2004	Acronym changed: Formerly known as PMDBUCOD.

PD8 – Date of death (Un) confirmation

Acronym: PDDCDATCN

Description: The date on which:

A patient was confirmed as being deceased during Death clearance processing, or
A PTCR revoked the Death clearance of a record: the CCR decision was rejected, or
A PTCR changed some death information: Date of death, province/territory or country of death or Death registration number.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (PD8)

Process	Read	Write
Data loading – posting	No	Yes*
Internal record linkage	No	No
Death clearance	No	Yes*
Tabulation master file	Yes	No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (PD8)

Value	Meaning
0000	Patient record never underwent Death clearance or not confirmed as deceased.
[0001-9999]	The year of date described above.

MM (PD8)

Value	Meaning
00	Patient record never underwent Death clearance or not confirmed as deceased.
[01-12]	The month of the date described above (January – December).

DD (PD8)

Value	Meaning
00	Patient record never underwent Death clearance or not confirmed as deceased.
[01-31]	The day of the date described above.

Revision (PD8)

Year	Description
2004	Acronym changed: Formerly known as PDCDATCN.

2.3 Input tumour variables

The input tumour variables are variables related to the tumour and reported by the PTCR. Table 12 lists all the input tumour variables; the following pages describe these variables in more details.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, CCR identification number is described on page T4 – CCR identification number.

Table 12 List of Input tumour variables

Variable N°	Variable	Acronym
T1	Tumour reporting province/territory	TREPPROV
T2	Tumour patient identification number	TPIN
T3	Tumour reference number	TTRN
T4	CCR identification number	CCR_ID
T5	Tumour record type	TRECTYPE
T6	Name of place of residence	TPLACRES
T7	Postal code	TPOSTCOD
T8	Standard geographic code	TCODPLAC
T9	Census tract	TCENTRAC
T10	Health insurance number	THIN
T11	Method of diagnosis	TMETHDIAG
T12	Date of diagnosis	TDATDIAG
T13	ICD–9 cancer code	TICD_9
T14	Source classification flag	TSCF
T15	ICD–O–2/3 Topography	TICD_O2T
T16	ICD–O–2 Histology	TICD_O2H
T17	ICD–O–2 Behaviour	TICD_O2B
T18	Not used	Not applicable
T19	Laterality	TLATERAL
T20	Not used	Not applicable
T21	ICD–O–3 Histology	TICD_O3H
T22	ICD–O–3 Behaviour	TICD_O3B
T23	Grade, differentiation or cell indicator	TGRADE
T24	Method used to establish the date of diagnosis	TMETHUSED
T25	Diagnostic confirmation	TMETHCONF
T26	Tumour date of transmission	TDATTRAN
T27	CS tumour size	TCSTSIZE
T28	CS extension	TCSEXTN
T29	CS tumour size/ext eval	TCSEVAL
T30	CS lymph nodes	TCSLNODE
T31	CS reg nodes eval	TCSRNEVAL
T32	Regional nodes examined	TCSRNEXAM
T33	Regional nodes positive	TCSRNPOS
T34	CS mets at Dx	TCSMDIAG
T35	CS mets eval	TCSMEVAL
T36	CS site-specific factor 1	TCSSSF1
T37	CS site-specific factor 2	TCSSSF2
T38	CS site-specific factor 3	TCSSSF3
T39	CS site-specific factor 4	TCSSSF4
T40	CS site-specific factor 5	TCSSSF5
T41	CS site-specific factor 6	TCSSSF6
T42	AJCC clinical T	TAJCCCLINT
T43	AJCC clinical N	TAJCCCLINN
T44	AJCC clinical M	TAJCCCLINM
T45	AJCC pathologic T	TAJCCPATHT
T46	AJCC pathologic N	TAJCCPATHN
T47	AJCC pathologic M	TAJCCPATHM
T48	AJCC clinical TNM stage group	TAJCCCLINSG
T49	AJCC pathologic TNM stage group	TAJCCPATHSG
T50	AJCC TNM stage group	TAJCCSG
T51	AJCC TNM edition number	TAJCCEDNUM
T52	CS Version 1st	TCSFVER
T53	Ambiguous Terminology Diagnosis	TAMBIGTERM
T54	Date of Conclusive Diagnosis	TDATCONCLUSDIAG
T55	Type of Multiple Tumours Reported as One Primary	TMULTTUMONEPRIM
T56	Date of Multiple Tumours	TDATMULT
T57	Multiplicity Counter	TMULTCOUNT

T1 – Tumour reporting province/territory

Acronym: TREPPROV

Description: The Standard geographic code (SGC) of the province/territory submitting the Tumour record to the CCR at time of diagnosis.

Refer to Appendix T (Part II – CCR System Guide) – Residency guidelines in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 2

Specific values & meaning (T1)

Value	Meaning
10	Newfoundland and Labrador
11	Prince Edward Island
12	Nova Scotia
13	New Brunswick
24	Quebec
35	Ontario
46	Manitoba
47	Saskatchewan
48	Alberta
59	British Columbia
60	Yukon
61	Northwest Territories
62	Nunavut

Related edits: TVAL1, TCOR1, TCOR4, KIM2, KIM3, KIM4, KIM5, KBM3, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T1)

Year	Description
2004	Related edits changed: See KIM4, KBM4 and DIM6.
1999	Specific values & meaning: Addition of Nunavut code (62).

T2 – Tumour patient identification number

Acronym: TPIN

Description: The unique identification number assigned by the provincial/territorial registry to each new patient registered.

This field is part of Statistics Canada Tumour record key. It cannot be updated or reused.

Effective: Reference year 1992 and onwards.

Length: 12

Related edits: TVAL2, TCOR1, KIM2, KIM3, KIM4, KIM5, KBM3, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T2)

Year	Description
2004	Acronym changed: Formerly known as PIN. Related edits changed: See TVAL2, KIM4, KBM4 and DIM6.

T3 – Tumour reference number

Acronym: TTRN

Description: The unique identification number assigned by the provincial/territorial cancer registry, as a reference, to each new tumour reported to the CCR.

It cannot be updated or reused.

Effective: Reference year 1992 and onwards.

Length: 9

Related edits: TVAL3, TCOR1, KIM2, KBM3, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6.

Revision (T3)

Year	Description
2004	Related edits changed: See TVAL3 and DIM6.

T4 – CCR identification number

Acronym: CCR_ID

Description:The unique number assigned by Statistics Canada to each new patient at the time of the initial registration in the CCR. 

It is used to link tumours with the corresponding patient. (P3 – CCR identification number)

Effective: Reference year 1992 and onwards.

Length: 9

Format:

It is composed of three parts:

1. Position 1–2: Last two digits of the year of the CCR Processing Date
2. Position 3–8: Sequential number from 000001–999999
3. Position 9: A check digit (See Appendix X (Part II– CCR System Guide) – CCR ID check digit routine)

Related edits: TVAL4, TCOR1, KIM3, KIM5, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T4)

Year	Description
2007	Format: Format of variable specified.
2004	Related edits changed: See KBM4 and DIM6.

T5 – Tumour record type

Acronym: TRECTYPE

Description: The code which identifies the type of record submitted to the CCR.

This field will not be stored or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (T5)

Value	Meaning
1	New record
2	Update record
3	Delete record

Related edits:TVAL5, TVAL6, TVAL7, TVAL8, TVAL9, TVAL10, TVAL11, TVAL12, TVAL13, TVAL14, TVAL15, TVAL16, TVAL17, TVAL19, TVAL21, TVAL22, TVAL23, TVAL24, TVAL25, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TVAL52, TVAL53, TVAL54, TVAL55, TVAL56, TVAL57, TCOR1, TCOR2, TCOR3, TCOR4, TCOR5, TCOR6, TCOR7, TCOR9, TCOR10, TCOR11, TCOR12, TCOR13, TCOR14, TCOR15, TCOR16, TCOR17, TCOR18, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR26, TCOR27, TCOR29, TCOR30, TCOR31, TCOR32, TCOR33, TCOR34, TCOR35, KIM3, KIM4, KIM5, KBM3, KBM4, KBM5, DIM1, DIM2, DIM3, DIM4, DIM5, DIM6, PPM1, PPM2.

Revision (T5)

Year	Description
2008	Related edits changed: See TVAL53, TVAL54, TVAL55, TVAL56, TVAL57, TCOR26, TCOR27, TCOR29, TCOR30, TCOR31, TCOR32, TCOR33, TCOR34, TCOR35
2007	Related edits changed: See TVAL52 and TCOR13
2004	Related edits changed: See TVAL18, TVAL20, TVAL23, TVAL27, TCOR1, TCOR5, TCOR6, TCOR7, TCOR9, TCOR10, TCOR11, TCOR12, TCOR14, TCOR15, TCOR16, TCOR17, KIM4, KBM1, KBM4 and DIM6.

T6 – Name of place of residence

Acronym: TPLACRES

Description: The name of the city, town, village, reserve, etc. of the patient's usual permanent place of residence at time of diagnosis.

Refer to Appendix T (Part II– CCR System Guide) – Residency guidelines in Canada for more details.

Effective: Reference year 1992 and onwards.

Length: 25

Format: Acceptable characters are limited to:

• Uppercase letters from ACSII-7 bit character set ([A-Z]);
• Lowercase letters from ACSII-7 bit character set ([a-z]);
• Accented characters (Â À Ç É Ê Ë È Î Ï Ô Û Ü â à ç é ê ë è î ï ô û ü)
• Special characters:
  • Spaces ( );
  • Periods (.);
  • Apostrophes (');
  • Hyphens (-);
  • Exclamation mark (!);
  • Ampersand (&);
  • Forward slash (/);
  • Parentheses ("and");
  • Number sign (#);
  • Comma (,).

Related edits: TVAL6 and TCOR1.

Revision (T6)

Year	Description
2007	Format: Acceptable characters are specified.

T7 – Postal code

Acronym: TPOSTCOD

Description: The Canadian postal code of the patient's usual permanent place of residence at time of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 6

Specific values & meaning (T7)

Value	Meaning
999999	Postal code unknown
[Others]	Postal code

Related edits: TVAL7, TCOR1 and TCOR2

Revision (T7)

Year	Description
Not applicable	Not applicable

T8 – Standard geographic code

Acronym: TCODPLAC

Description: The Standard geographic code of the patient's usual permanent place of residence at time of diagnosis.

It is coded using Standard geographic classification (SGC) - 1991, 1996, 2001 or 2006 depending on the Date of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 7

Format: PRCDCSD where PR (2 first digits) is the Province code, CD (3^rd and 4^th digits) is the Census division code and CSD (3 last digits) is the Census subdivision code.

Specific values & meaning (T8)

Value	Meaning
10	Newfoundland and Labrador
11	Prince Edward Island
12	Nova Scotia
13	New Brunswick
24	Quebec
35	Ontario
46	Manitoba
47	Saskatchewan
48	Alberta
59	British Columbia
60	Yukon
61	Northwest Territories
62	Nunavut

CD (T8)

Value	Meaning
00	Unknown Census division
[Others]	For Date of diagnosis between 1992 and 1995, refer to Appendix A (Part III– CCR System Guide )– Core reference tables – Eligible standard geographic classification codes from 1992 to 1995 for meaning. For Date of diagnosis between 1996 and 2000, refer to Appendix A (Part III– CCR System Guide)– Core reference tables – Eligible standard geographic classification codes from 1996 to 2000 for meaning. For Date of diagnosis between 2001 and 2005, refer to Appendix A (Part III– CCR System Guide) – Core reference tables – Eligible standard geographic classification codes from 2001 to 2005 for meaning. For Date of Diagnosis between 2006 and 2010, refer to Appendix A (Part III– CCR System Guide) – Core Reference Tables – Eligible Standard Geographic Classification Codes from 2006 to 2010 for meaning.

CSD (T8)

Value	Meaning
999	Unknown Census subdivision
[Others]	For Date of diagnosis between 1992 and 1995, refer to Appendix A (Part III– CCR System Guide ) – Core reference tables – Eligible standard geographic classification codes from 1992 to 1995 for meaning. For Date of diagnosis between 1996 and 2000, refer to Appendix A (Part III– CCR System Guide) – Core reference tables – Eligible standard geographic classification codes from 1996 to 2000 for meaning. For Date of diagnosis between 2001 and 2005, refer to Appendix A (Part III– CCR System Guide) – Core reference tables – Eligible standard geographic classification codes from 2001 to 2005 for meaning. For Date of Diagnosis between 2006 and 2010, refer to Appendix A (Part III– CCR System Guide) – Core Reference Tables – Eligible Standard Geographic Classification Codes from 2006 to 2010 for meaning.

Related edits: TVAL8, TCOR1, TCOR2, TCOR3, TCOR4.

Revision (T8)

Year	Description
2006	Specific values & meaning: SGC – 2006 added.
2001	Specific values & meaning: SGC – 2001 added.
1996	Specific values & meaning: SGC – 1996 added.

T9 – Census tract

Acronym: TCENTRAC

Description: The geostatistical area of the patient's usual permanent place of residence at time of diagnosis.

Census tracts are found only in large urban communities and contain populations ranging from 2500 to 8000, with an average of 4000. They are designed as being as homogeneous as possible in terms of economic status and social conditions. All Census metropolitan areas (CMA) and Census agglomerations (CA), containing a Census subdivision (that is, a city) having a population of at least 50000, are eligible to have Census tracts.

It is coded using Census tract dictionary – 1991, 1996 or 2001 depending on the Date of diagnosis.

Effective: Reference year 1992 to 2005.

Length: 9

Format: For cases diagnosed in 2006 and onwards, leave the field blank.

For cases diagnosed between 1992 and 2005, enter a value using the CMACCC.TT format where CMA (3 first digits) is the Census metropolitan area/Census agglomeration and CCC.TT (6 last digits) is the Census tract.

Specific values & meaning (T9)

Value	Meaning
[Blank]	For cases outside the effective date range (for example, cases diagnosed in 2006 and onwards)
000000.00	Place of residence not in a Census tract
999999.99	Census tract unknown/incomplete address
[Others]	For Date of diagnosis between 1992 and 1995, refer to Census tract dictionary – 1991³ for meaning. For Date of diagnosis between 1996 and 2000, refer to Census tract dictionary – 1996³ for meaning. For Date of diagnosis between 2001 and 2005, refer to Census tract dictionary – 2001³ for meaning.

Related edits: TVAL9, TCOR1, TCOR3.

Revision (T9)

Year	Description
2006	Effective dates: Field is only effective for reference years 1992 to 2005. For 2006 cases and onwards, this field will be reported as blank (null). Census tract was removed for all cases diagnosed in 2006. Specific values & meaning: Null (blank) value added.
2001	Specific values & meaning: Census tract dictionary – 2001 added.
1996	Specific values & meaning: Census tract dictionary – 1996 added.

T10 – Health insurance number

Acronym: THIN

Description: The patient's provincial/territorial health insurance number at time of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 15

Specific values & meaning (T10)

Value	Meaning
999999999999999	Unknown
[Others]	Health insurance number

Related edits: TVAL10, TCOR1.

Revision (T10)

Year	Description
Not applicable	Not applicable

T11 – Method of diagnosis

Acronym: TMETHDIAG

Description: The code that represents the most definitive procedure by which the tumour was diagnosed.

In general, the method of diagnosis should be based on the method by which the earliest microscopic date of diagnosis was determined. The method should be based on the status before any treatment other than surgery is given.

It is not linked to the Date of diagnosis.

Effective: Reference year 1992 to 2003.

Length: 1

Specific values & meaning (T11)

Value	Meaning
0	For Date of diagnosis in 2004 and onward. Method of diagnosis reported in Input tumour variables: T24 – Method used to establish the date of diagnosis and; T25 – diagnostic confirmation.
1	Histology
2	Autopsy
3	Cytology
4	Radiology or laboratory diagnosis other than specified above
5	Surgery (without histology), or clinical diagnosis
6	Death certificate only4
9	Method of diagnosis unknown

Related edits: TVAL11, TCOR1, TCOR14, DIM3.

Revision (T11)

Year	Description
2004	Acronym changed: Formerly known as TMETDIAG. Specific values & meaning: Code added (0) to handle Date of Diagnosis in 2004 and onwards. Related edits changed: See TCOR14.

T12 – Date of diagnosis

Acronym: TDATDIAG

Description: The date of diagnosis of the tumour. It is determined using the following sequence order (effective since 2004 for all data):

1. Date of cytological diagnosis
   
   If suspicious cytology is confirmed by subsequent histological diagnosis (including autopsy) or clinical impression of cancer supports the cytology findings, then the cytological diagnosis date will be used.
    
2. Date of histological diagnosis, including cases diagnosed only on autopsy
    
3. Date of non microscopically confirmed diagnosis. including:
    

   a)Positive laboratory test/marker study;
   b)Direct visualization without microscopic confirmation (surgery without histology);
   c)Radiography and other imaging techniques without microscopic confirmation;
   d)Clinical diagnosis, including: physical findings (without histology); 
   e)Method of Diagnosis unknown.

4. Date of death, if not reported at any other time.Includes:
    

   a) Death certificate only;
   b) Autopsy only.

Exceptions
1. If applicable, the date associated with the method that prompts treatment takes precedence over the above choices and should be chosen.
2. If autopsy only case, follow back as per the Guidelines for abstracting and determining DCO cases for PTCRs in Canada (see Appendix I (Part II – CCR System Guide)). If previous information is available for this tumour, the initial date takes precedence, including if it is non microscopic information. For example, if an x-ray result is available prior to the autopsy; the date associated with this initial diagnostic information takes precedence over the autopsy (histological) date.

Refer to the CCR guidelines for ambiguous terms (See Appendix H (Part II – CCR System Guide)) when determining the date of diagnosis.

Date of diagnosis is linked to the Input tumour variable T24 - Method used to establish the date of diagnosis.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T12)

Value	Meaning
[0000-9999]	Year of diagnosis (1992 to current reference year)

MM (T12)

Value	Meaning
[01-12]	Month of diagnosis (January – December)
99	Month of diagnosis unknown

DD (T12)

Value	Meaning
[01-31]	Day of diagnosis
99	Day of diagnosis unknown

Related edits: TVAL8, TVAL9, TVAL12, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TVAL52, TCOR1, TCOR3, TCOR9, TCOR10, TCOR11, TCOR12, TCOR13, TCOR14, TCOR15, TCOR16, TCOR17, TCOR18, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR26, TCOR27, TCOR30, DIM1, DIM2, DIM3, DIM4, DIM6

Revision (T12)

Year	Description
2008	Related edits changed: See TCOR26, TCOR27 and TCOR30.
2007	Related edits changed: See TVAL52 and TCOR13.
2004	Description: New sequence order. Related edits changed: See TVAL27, TCOR9, TCOR12, TCOR14, TCOR15, TCOR16, TCOR17, TCOR18, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23 and TCOR24.

T13 – ICD–9 cancer code

Acronym: TICD_9

Description:The diagnosis of the neoplasm coded according to the International Classification of Diseases, 9^th revision.

ICD-9 Cancer code is used to describe the site of the tumour, and must be supplemented with an ICD–O–2 Histology (field T16) and an ICD–O–2 Behaviour (field T17).

Effective: Reference year 1992 and onwards.

Length: 4

Format:

• The value does not contain a period between the 3^rd and 4^th digits
• 3 digit long values are followed by a blank space in the 4^th digit

Specific values & meaning (T13)

Value	Meaning
0000	Topography not reported using ICD-9.
[Others]	Refer to Appendix A (Part III – CCR System Guide) – Core reference tables - Eligible ICD-9 Cancer codes for meaning.

Related edits:TVAL13, TCOR1, TCOR5, TCOR6.

Revision (T13)

Year	Description
2004	Name: Formerly known as T13 – ICD-9. Related edits changed: TCOR5 and TCOR6.

T14 – Source classification flag

Acronym: TSCF

Description: The code that indicates the classification system in which the topography, histology and behaviour of the tumour were originally coded.

It is assumed that other reported topography, histology and behaviour are the result of a conversion from the original source code.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (T14)

Value	Meaning
1	Topography originally coded in ICD–9, Histology and behaviour originally coded in ICD–O–2
2	Topography, histology and behaviour originally coded in ICD–O–2
4	Topography, histology and Behaviour originally coded in ICD–O–3

Related edits: TVAL14, TCOR1, TCOR5, TCOR6, TCOR7.

Revision (T14)

Year	Description
2004	Specific values & meaning: Code 3 (ICD-10) removed from the eligible codes. Related edits changed: See TCOR5, TCOR6 and TCOR7.

T15 – ICD–O–2/3 Topography

Acronym: TICD_O2T

Description: The site of origin of the neoplasm coded according to the International Classification of diseases for oncology (2^nd or 3^rd edition) topography section.

Effective: Reference year 1992 and onwards.

Length: 4

Format: The value does not contain a period (.) between the 3^rd and 4^th digits.

Specific values & meaning (T15)

Value	Meaning
0000	Topography not reported using ICD-O-2/3. If possible, ICD-O-2/3 Topography will automatically be derived from ICD-9 Cancer code by the CCR system.
[Others]	Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible ICD–O–2/3 topography codes for meaning.

Related edits: TVAL15, TVAL16, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR1, TCOR6, TCOR7, TCOR9, TCOR10, TCOR12, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR31, TCOR33, DIM5, DIM6.

Revision (T15)

Year	Description
2008	Related edits changed: See TCOR31, TCOR33
2004	Related edits changed: See TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR6, TCOR7, TCOR9, TCOR10, TCOR12, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24 and DIM6.

T16 – ICD–O–2 Histology

Acronym: TICD_O2H

Description: The histological description of the neoplasm, coded according to the International Classification of Diseases for Oncology 2^nd edition - Morphology Section.

Effective: Reference year 1992 and onwards.

Length: 4

Specific values & meaning (T16)

Value	Meaning
0000	Histology not reported using ICD-O-2.
[Others]	Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible ICD–O–2 histology codes for meaning.

Related edits: TVAL16, TCOR1, TCOR5, TCOR6, TCOR7.

Revision (T16)

Year	Description
2004	Name: Formerly known as T16 – ICD-O-2 Morphology. Renamed according to CCR data and quality management Committee recommendation. Acronym: Formerly known as TICD_O2M. Changed to reflect new name. Related edits changed: See TCOR5, TCOR6 and TCOR7.

T17 – ICD–O–2 Behaviour

Acronym: TICD_O2B

Description: The behaviour associated with the histological description of the neoplasm, reported in Field T16.

Effective: Reference year 1992 and onwards.

Length: 1

Specific values & meaning (T17)

Value	Meaning
0	Benign if ICD-O-2 Histology is reported – OR – Behaviour not reported using ICD–O–2
1	Uncertain whether benign or malignant / borderline malignancy
2	Carcinoma in situ / intraepithelial / non-infiltrating / non-invasive
3	Malignant, primary site

Related edits: TVAL17, TCOR1, TCOR5, TCOR6, TCOR7.

Revision (T17)

Year	Description
2004	Name: Formerly known as T17 – ICD-O-2 M Behaviour. Renamed to be consistent with T16 new name. Related edits changed: See TCOR6 and TCOR7.

T18 – Filler

Acronym: Not applicable

Description: Filler: free space reserved for future requirement implementation.

This field will not be processed or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 4

Format: Enter any values or leave the field blank.

Revision (T18)

Year	Description
Not applicable	Not applicable

T19 – Laterality

Acronym: TLATERAL

Description: The site-specific localization of the tumour in paired organs or the side of the body on which the tumour originated. It specifies whether the tumour is on the right, left or bilateral, where applicable.

Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Valid site and laterality combinations for more details.

Effective: Reference year 1992 and onwards.

Length: 1

For date of diagnosis 2007 and onwards:

Specific values & meaning (T19)

Value	Meaning
0	Not a paired organ
1	Right: origin of primary
2	Left: origin of primary
3	Only one side involved, right or left origin unspecified
4	Bilateral involvement, lateral origin unknown: stated to be single primary This code is seldom used EXCEPT for the following diseases: i.Both ovaries involved simultaneously, single histology ii. Bilateral retinoblastomas iii. Bilateral Wilm's tumours
9	Paired site, but no information concerning laterality, midline tumour

For date of diagnosis between 1992 and 2006:

Specific values & meaning (T19)

Value	Meaning
0	Not a paired organ
1	Right: origin of primary
2	Left: origin of primary
4	Bilateral involvement, lateral origin unknown: stated to be single primary This code is seldom used EXCEPT for the following diseases: i.Both ovaries involved simultaneously, single histology ii.Bilateral retinoblastomas iii. Bilateral Wilm's tumours
9	Paired site, but no information concerning laterality, midline tumour

Related edits: TVAL19, TCOR1, TCOR12, DIM6.

Revision (T19)

Year	Description
2007	Specific values & meaning: NAACCR (SEER) laterality codes and meaning are now used for this variable. Code'1' now refers to 'Right: origin of primary'. Code '2' now refers to 'Left: origin of primary'. Code '3' added to handle 'Only one side involved, right or left origin unspecified. Data already loaded in the CCR (1992-2006) has been updated to reflect the new code set (note: Code '3' was not implemented for cases diagnosed prior to 2007).
2004	Related edits changed: See TCOR12 and DIM6.

T20 – Filler

Acronym: Not applicable

Description: Filler: free space reserved for future requirement implementation.

This field will not be processed or returned by the CCR System.

Effective: Reference year 1992 and onwards.

Length: 1

Format: Enter any values or leave the field blank.

Revision (T20)

Year	Description
Not applicable	Not applicable

T21 – ICD–O–3 Histology

Acronym: TICD_O3H

Description: The histological description of the neoplasm, coded according to the International Classification of Diseases for Oncology 3^rd edition - Morphology Section.

Effective: Reference year 1992 and onwards.

Although this field was added to the CCR in 2001, historical data back to 1992 has been converted to this classification.

Length: 4

Specific values & meaning (T21)

Value	Meaning
0000	Histology not reported using ICD-O-3. ICD-O-3 Histology will automatically be derived from ICD-O-2 fields (topography, histology and behaviour) by the CCR system.
[Others]	Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible ICD–O–3 histology codes for meaning.

Related edits: TVAL21, TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR1, TCOR7, TCOR9, TCOR10, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR33, DIM6.

Revision (T21)

Year	Description
2008	Related edits changed: See TCOR33
2004	Name: Formerly known as T21M – ICD-O-3 Morphology. renamed according to CCR data and quality management committee recommendation. Renumbered to fit in sequence. Acronym: Formerly known as TICD_O3M. Changed to reflect new name. Related edits changed: See TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR7, TCOR9, TCOR10, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24 and DIM6.

T22 – ICD–O–3 Behaviour

Acronym: TICD_O3B

Description: The behaviour associated with the histological description of the neoplasm, reported in Field T21.

Effective: Reference year 1992 and onwards.

Although this field was added to the CCR in 2001, historical data back to 1992 has been converted to this classification.

Length: 1

Specific values & meaning T22)

Value	Meaning
0	Benign if ICD-O-3 Histology is reported – OR – Behaviour not reported using ICD–O–3. If not reported, ICD-O-3 Behaviour will automatically be derived from ICD-O-2 fields (topography, histology and behaviour) by the CCR system.
1	Uncertain whether benign or malignant / borderline malignancy
2	Carcinoma in situ / intraepithelial / non-infiltrating / non-invasive
3	Malignant, primary site

Related edits: TVAL22, TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR1, TCOR7, TCOR9, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23, TCOR24, TCOR32.

Revision (T22)

Year	Description
2008	Related edits changed: TCOR32
2004	Fields reorganized: Field formerly known as T22 – Date of transmission has been moved to T26 – Date of transmission. Name: Current field formerly know as T21B – ICD-O-3 M Behaviour. Renamed to be consistent with T21 new name. Renumbered to fit in sequence. Related edits changed: See TVAL42, TVAL43, TVAL44, TVAL45, TVAL46, TVAL47, TVAL48, TVAL49, TVAL50, TVAL51, TCOR7, TCOR9, TCOR11, TCOR19, TCOR20, TCOR21, TCOR22, TCOR23 and TCOR24.

T23 – Grade, differentiation or cell indicator

Acronym: TGRADE

Description: The code that describes the system used to identify the Type of grade/differentiation/cell indicator.

Grade is used by the CS algorithm to produce CS derived data.

Refer to Appendix G (Part II – CCR System Guide)– Guidelines for reporting grade, differentiation or cell indicator for 2006 data forward.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T23)

Value	Meaning
0	For Date of diagnosis prior to 2004. Not reported
1	Grade I; grade i; grade 1; well differentiated; differentiated, NOS
2	Grade II; grade ii; grade 2; moderately differentiated; moderately well differentiated; intermediate differentiation
3	Grade III; grade iii, grade 3; poorly differentiated; dedifferentiated
4	Grade IV; grade iv; grade 4; undifferentiated; anaplastic
5	T-cell; T-precursor
6	B-Cell; Pre-B; B-precursor
7	Null cell; Non T-non B
8	NK cell (natural killer cell)
9	Grade/differentiations unknown, not stated, or not applicable

Related edits: TVAL23, TCOR1, TCOR17.

Revision (T23)

Year	Description
2006	Application of new guidelines for reporting grade, differentiation or cell indicator
2004	Fields reorganized: Field formerly known as T23 – Method used to establish date of diagnosis has been moved to T24 – Method used to establish the date of diagnosis.

T24 – Method used to establish the date of diagnosis

Acronym: TMETHUSED

Description: The code that specifies the method by which the date of diagnosis of this tumour was established.

The SEER Program Code Manual, third edition, diagnostic confirmation descriptions were used as a reference when determining the appropriate codes for the CCR.

This field is linked to T12 – Date of diagnosis.

Effective: Reference year 2004 and onwards.

Length: 1

Categories of diagnostic methods are listed below in order of priority.

Specific values & meaning (T24)

Value	Meaning
0	For Date of diagnosis prior to 2004 Not reported. (Refer to T11 – Method of diagnosis.)
1-3	Microscopically confirmed
1	Positive cytology Cytological diagnoses based on microscopic examination of cells as contrasted with tissues. Included are smears from sputum, bronchial brushings, bronchial washings, tracheal washings, prostatic secretions, breast secretions, gastric fluid, spinal fluid, peritoneal fluid, and urinary sediment. Cervical and vaginal smears are common examples. Also included are diagnoses based upon paraffin block specimens from concentrated spinal, pleural and peritoneal fluid. Fine needle aspiration is included here.
2	Positive histology Histological diagnoses based upon tissue specimens from biopsy (including wide core and needle biopsy), frozen section, surgery, autopsy or D and C. Positive hematological findings relative to leukemia, including peripheral blood smears, are also included. Bone marrow specimens (including aspiration biopsies) are coded as '2'.
3	Autopsy only Diagnosis confirmed by autopsy only, (if tissue taken) when no other information available.
4-9	Non-microscopically confirmed
4	Positive laboratory test/marker study Clinical diagnoses of cancer based on certain laboratory tests or marker studies, which are clinically diagnostic for cancer. This includes alpha-fetoprotein for liver cancer and abnormal electrophoretic spike for multiple myeloma. Elevated PSA is non-diagnostic for cancer. If the physician uses the PSA as a basis for diagnosing prostate cancer with no other work-up, it should be recorded as code 4.
5	Direct visualization without microscopic confirmation (surgery without histology) Visualization includes diagnosis made at surgical exploration, including autopsy where no tissue is taken, or by use of the various endoscopes (including colposcope, mediastinoscope, and peritoneoscope). However, use only if such visualization is not supplemented by positive histology or positive cytology reports.
6	Radiography and other imaging techniques without microscopic confirmation Cases with diagnostic radiology for which there is neither a positive histology nor a positive cytology report. 'Other imaging techniques' include procedures such as ultrasound, computerized (axial) tomography (CT or CAT) scans, and magnetic resonance imaging (MRI).
7	Clinical diagnosis, including physical findings (without histology) Cases diagnosed by clinical methods not mentioned above and for which there were no positive microscopic findings.
8	Death certificate only Cases diagnosed by Death certificates only, when no other information available.
9	Method used to establish the date of diagnosis unknown.

Related edits: TVAL24, TCOR1, TCOR13, TCOR15, TCOR33, TCOR35, DIM4.

Revision (T24)

Year	Description
2008	Related edits changed: See TCOR33, TCOR35
2006	Related edits changed: See TCOR13.
2004	Fields reorganized: Field formerly known as T24 – Diagnosis confirmation has been moved to T25 – Diagnosis confirmation. Name: Current field formerly known as T23 – Method used to establish the date of diagnosis. Renumbered to fit in sequence.

T25 – Diagnostic confirmation

Acronym: TMETHCONF

Description: The method of the most accurate diagnostic confirmation. Determine whether this tumour was microscopically confirmed at any time during the patient's medical history.

The SEER Program Code Manual, third edition, diagnostic confirmation descriptions were used as a reference when determining the appropriate codes for the CCR.

This field is not linked with T12 – Date of diagnosis.

Effective: Reference year 2004 and onwards.

Length: 1

Categories of diagnostic methods are listed below in order of priority.

Specific values & meaning (T25)

Value	Meaning
0	For Date of diagnosis prior to 2004 Not reported. (Refer to T11 – Method of diagnosis.)
1-3	Microscopically confirmed
1	Positive histology Histological diagnoses based upon tissue specimens from biopsy (including wide core and needle biopsy), frozen section, surgery, autopsy or D and C. Positive hematological findings relative to leukemia, including peripheral blood smears, are also included. Bone marrow specimens (including aspiration biopsies) are coded as '1'.
2	Positive cytology Cytological diagnoses based on microscopic examination of cells as contrasted with tissues. Included are smears from sputum, bronchial brushings, bronchial washings, tracheal washings, prostatic secretions, breast secretions, gastric fluid, spinal fluid, peritoneal fluid, and urinary sediment. Cervical and vaginal smears are common examples. Also included are diagnoses based upon paraffin block specimens from concentrated spinal, pleural and peritoneal fluid. Fine needle aspiration included here.
3	Autopsy only Diagnosis confirmed by autopsy only, (if tissue taken) when no other information available
4-9	Non-microscopically confirmed
4	Positive laboratory test/marker study Clinical diagnoses of cancer based on certain laboratory tests or marker studies, which are clinically diagnostic for cancer. This includes alpha-fetoprotein for liver cancer and abnormal electrophoretic spike for multiple myeloma. Elevated PSA is non-diagnostic for cancer. If the physician uses the PSA as a basis for diagnosing prostate cancer with no other work-up, it should be recorded as code 4.
5	Direct visualization without microscopic confirmation (surgery without histology) Visualization includes diagnosis made at surgical exploration including autopsy where no tissue is taken, or by use of the various endoscopes (including colposcope, mediastinoscope, and peritoneoscope). However, use only if such visualization is not supplemented by positive histology or positive cytology reports.
6	Radiography and other imaging techniques without microscopic confirmation Cases with diagnostic radiology for which there is neither a positive histology nor a positive cytology report. 'Other imaging techniques' include procedures such as ultrasound, computerized (axial) tomography (CT or CAT) scans, and magnetic resonance imaging (MRI).
7	Clinical diagnosis, including physical findings (without histology) Cases diagnosed by clinical methods not mentioned above and for which there were no positive microscopic findings.
8	Death certificate only Cases diagnosed by Death certificates only, when no other information available.
9	Diagnostic confirmation unknown

Related edits: TVAL25, TCOR1, TCOR13, TCOR16

Revision (T25)

Year	Description
2006	Related edits changed: See TCOR13.
2004	Name: Formerly known as T24 – Diagnostic confirmation. Renumbered to fit in sequence.

T26 – Date of transmission

Acronym: TDATTRAN

Description: The date on which a copy of the tumour record was extracted from the provincial/territorial registry for submission to the CCR.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T26)

Value	Meaning
[0000-9999]	Year of transmission

MM (T26)

Value	Meaning
[01-12]	Month of transmission (January – December)

DD (T26)

Value	Meaning
[01-31]	Day of the transmission

Related edits: TVAL26.

Revision (T26)

Year	Description
2004	Name: Formerly known as T22 – Date of transmission. Renumbered to fit in sequence. Acronym: Formerly known as TDATTRA2.

T27 – CS tumour size

Acronym: TCSTSIZE

Description: The largest dimension or the diameter of the primary tumour in millimetres (for example: 1 mm = 001, 1 cm = 010). See the CS schemas for site-specific variants.

For many sites, the CS algorithm uses this data item to calculate the Derived T or Derived M according to the AJCC Cancer staging manual, sixth edition.

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T27)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR Collaborative Scope).
[000-998]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18.

Revision (T27)

Year	Description
2007	Specific values & meaning: Meaning of value '999' modified Related edits changed: See TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T28 – CS extension

Acronym: TCSEXTN

Description: The primary tumour growth within the organ of origin or its direct extension into neighbouring organs.

This data item is used by the algorithm to derive the AJCC T code according to the AJCC Cancer staging manual, sixth edition.

For certain sites such as ovary, discontinuous metastasis is coded in the CS extension field. 

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T28)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
99	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning
RR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18.

Revision (T28)

Year	Description
2007	Specific values & meaning: Meaning of value '99' modified Related edits changed: See TVAL27, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T29 – CS tumour size/ext eval

Acronym: TCSEVAL

Description: CS tumour size/extension evaluation: the code indicating how the 'CS tumour size' and 'CS extension' were determined based on the diagnostic methods employed.

This data item is used in CS to identify whether the T (of AJCC TNM) was clinically or pathologically diagnosed and by what method 'CS tumour size/ext eval' is used to calculate the derived AJCC T descriptor.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T29)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section1.1.2.2. CCR collaborative staging scope).
[0-8]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
9	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning
R	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18.

Revision (T29)

Year	Description
2007	Specific values & meaning: Meaning of value '9' modified Related edits changed: See TVAL27, TVAL28, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T30 – CS lymph nodes

Acronym: TCSLNODE

Description: The site-specific code identifying the regional lymph nodes involved with cancer at time of diagnosis.

This data item is used by the algorithm to derive the AJCC N code according to the AJCC Cancer staging manual, sixth edition.

Site-specific codes provide extensive detail describing disease extent. 

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T30)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
99	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T30)

Year	Description
2007	Specific values & meaning: Meaning of value '99' modified Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T31 – CS reg nodes eval

Acronym: TCSRNEVAL

Description: CS regional nodes evaluation: the code indicating how the 'CS Lymph Nodes' code was determined based on the diagnostic methods employed.

This data item is used in CS to identify whether the N (of AJCC TNM) was clinically or pathologically diagnosed and by what method 'CS reg nodes eval' is used to calculate the Derived AJCC nodes descriptor.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T31)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[0-8]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
9	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
R	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T31)

Year	Description
2007	Specific values & meaning: Meaning of value '9' modified Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T32 – Regional nodes examined

Acronym: TCSRNEXAM

Description: The total number of regional lymph nodes that were removed and examined by the pathologist.

Based on pathologic (microscopic) information only.

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning(T32)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2.CCR collaborative staging scope).
[00-98]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
99	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T32)

Year	Description
2007	Specific values & meaning: Meaning of value '99' modified Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T33 – Regional nodes positive

Acronym: TCSRNPOS

Description: The exact number of regional lymph nodes examined by the pathologist and found to contain metastases.

Based on pathologic (microscopic) information only.

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T33)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
99	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T33)

Year	Description
2007	Specific values & meaning: Meaning of value '99' modified Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T34 – CS mets at dx

Acronym: TCSMDIAG

Description: CS metastases at diagnosis: the code identifying the distant site(s) of metastatic involvement at time of diagnosis.

This data item is used by the algorithm to derive the AJCC M code according to the AJCC Cancer staging manual, sixth edition.

Effective: Reference year 2004 and onwards.

Length: 2

Specific values & meaning (T34)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[00-98]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
99	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T34)

Year	Description
2007	Specific values & meaning: Meaning of value '99' modified Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T35 – CS mets eval

Acronym: TCSMEVAL

Description: CS metastases evaluation: the code indicating how 'CS mets at dx' was determined based on the diagnostic methods employed.

This data item is used in CS to identify whether the M (of AJCC TNM) was clinically or pathologically diagnosed and by what methods 'CS mets eval' is used to calculate the Derived AJCC M descriptor.

Effective: Reference year 2004 and onwards.

Length: 1

Specific values & meaning (T35)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[0-8]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
9	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
R	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T35)

Year	Description
2007	Specific values & meaning: Meaning of value '9' modified Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52

T36 – CS site-specific factor 1

Acronym: TCSSSF1

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T36)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope)
888	Not applicable; specific schema does not use CS site-specific factor 1
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T36)

Year	Description
2007	Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified. Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52.

T37 – CS site-specific factor 2

Acronym: TCSSSF2

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T37)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
888	Not applicable; specific schema does not use CS site-specific factor 2.
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T37)

Year	Description
2007	Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified. Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52.

T38 – CS site-specific factor 3

Acronym: TCSSSF3

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T38)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
888	Not applicable; specific schema does not use CS site-specific factor 3.
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T38)

Year	Description
2007	Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified. Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL39, TVAL40, TVAL41 and TVAL52.

T39 – CS site-specific factor 4

Acronym: TCSSSF4

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T39)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
888	Not applicable; specific schema does not use CS site-specific factor 4.
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T39)

Year	Description
2007	Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified. Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL40, TVAL41 and TVAL52.

T40 – CS site-specific factor 5

Acronym: TCSSSF5

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T40)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope)
888	Not applicable; specific schema does not use CS site-specific factor 5.
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T40)

Year	Description
2007	Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified. Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL41 and TVAL52.

T41 – CS site-specific factor 6

Acronym: TCSSSF6

Description: The code identifying additional site-specific information needed to derive TNM or AJCC stage, or to code prognostic factors that have an effect on stage or survival. 

Many site-specific schemas do not use any of the Site-specific factors; other schemas use from 1 to all 6 of the factors. When the Site-specific factors are not used for a specific schema, the value will be entered as '888' (Not applicable).

Effective: Reference year 2004 and onwards.

Length: 3

Specific values & meaning (T41)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope.
888	Not applicable; specific schema does not use CS site-specific factor 6.
999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
[others]	See the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning. Some values in the range may be invalid depending on site.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T41)

Year	Description
2007	Specific values & meaning: Code 888 specified for schemas that do not use the site-specific factor. Meaning of value '999' has also been modified. Related edits changed: See TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41 and TVAL52.

T42 – AJCC clinical T

Acronym: TAJCCCLINT

Description: The site-specific code evaluating the primary tumour clinically (T) and reflects the tumour size and/or extension as recorded.

Clinical stage is assigned prior to any cancer-directed treatment and should not be changed based on subsequent information.

Effective: Reference year 2003 and onwards.

Length: 9

Specific values & meaning (T42)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
TX	Primary tumour cannot be assessed (all reasonable clinical manoeuvres have been used).
T0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
Tis
TisDCIS
TisLCIS
TisPagets
T1
T1mic
T1a
T1b
T1c
T2
T2a
T2b
T2c
T3
T3a
T3b
T4
T4a
T4b
T4c
T4d
99	AJCC clinical T is unknown.
RRRRRRRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL42, TCOR1, TCOR19, TCOR21, TCOR23, TCOR24

Revision (T42)

Year	Description
Not applicable	Not applicable

T43 – AJCC clinical N

Acronym: TAJCCCLINN

Description: The site-specific code identifying the absence or presence of clinical regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis as recorded. 

Clinical stage is assigned prior to any cancer-directed treatment and should not be changed based on subsequent information.

Effective: Reference year 2003 and onwards.

Length: 3

Specific values & meaning (T43)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
NX	Regional lymph nodes cannot be assessed (all reasonable clinical manoeuvres have been used).
N0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
N1
N2
N2a
N2b
N3
N3a
N3b
N3c
99	AJCC clinical N is unknown.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL43, TCOR1, TCOR19, TCOR21, TCOR23, TCOR24

Revision (T43)

Year	Description
Not applicable	Not applicable

T44 – AJCC clinical M

Acronym: TAJCCCLINM

Description: The site-specific code identifying the presence or absence of clinical distant metastasis (M) as recorded.

Clinical stage is assigned prior to any cancer-directed treatment and should not be changed based on subsequent information. 

Effective: Reference year 2003 and onwards.

Length: 3

Specific values & meaning (T44)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
MX	Distant metastasis cannot be assessed (all reasonable clinical manoeuvres have been used).
M0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
M1
M1a
M1b
M1c
99	AJCC clinical M is unknown.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL44, TCOR1, TCOR19, TCOR21, TCOR23, TCOR24

Revision (T44)

Year	Description
Not applicable	Not applicable

T45 – AJCC pathologic T

Acronym: TAJCCPATHT

Description: The site-specific code evaluating the primary tumour pathologically (T) and reflects the tumour size and/or extension as recorded. 

Pathological stage uses all data for clinical staging; the evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination.

Effective: Reference year 2003 and onwards.

Length: 9

Specific values & meaning (T45)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
TX	Primary tumour cannot be assessed (all reasonable pathologic manoeuvres have been used).
T0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
Tis
TisDCIS
TisLCIS
TisPagets
T1
T1mic
T1a
T1b
T1c
T2
T2a
T2b
T2c
T3
T3a
T3b
T4
T4a
T4b
T4c
T4d
99	AJCC pathologic T is unknown.
RRRRRRRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL45, TCOR1, TCOR19, TCOR22, TCOR23, TCOR24

Revision (T45)

Year	Description
Not applicable	Not applicable

T46 – AJCC pathologic N

Acronym: TAJCCPATHN

Description: The site-specific code identifying the absence or presence of pathological regional lymph node (N) metastasis and describes the extent of regional lymph node metastasis as recorded. 

Pathological stage uses all data for clinical staging; the evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination.

Effective: Reference year 2003 and onwards.

Length: 6

Specific values & meaning (T46)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
NX	Regional lymph nodes cannot be assessed (all reasonable pathologic manoeuvres have been used).
N0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
N0i-
N0i+
N0mol-
N0mol+
N1
N1mi
N1a
N1b
N1c
N2
N2a
N2b
N3
N3a
N3b
N3c
99	AJCC pathologic N is unknown.
RRRRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL46, TCOR1, TCOR19, TCOR22, TCOR23, TCOR24

Revision (T46)

Year	Description
Not applicable	Not applicable

T47 – AJCC pathologic M

Acronym: TAJCCPATHM

Description: The site-specific code identifying the presence or absence of pathological distant metastasis (M) as recorded.

Pathological stage uses all data for clinical staging; the evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination.

Effective: Reference year 2003 and onwards.

Length: 3

Specific values & meaning (T47)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
MX	Distant metastasis cannot be assessed (all reasonable pathologic manoeuvres have been used).
M0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
M1
M1a
M1b
M1c
99	AJCC pathologic M is unknown.
RRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL47, TCOR1, TCOR19, TCOR22, TCOR23, TCOR24

Revision (T47)

Year	Description
Not applicable	Not applicable

T48 – AJCC clinical TNM stage group

Acronym: TAJCCCLINSG

Description: The site-specific code identifying the anatomic extent of disease based on the clinical T, N and M elements as recorded in TNM Clinical T, N and M fields.

Effective: Reference year 2003 and onwards.

Length: 4

Specific values & meaning (T48)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
X	All reasonable clinical manoeuvres have been used, but Clinical TNM values do not lead to a certain, specific stage group.
0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
I
II
IIA
IIB
III
IIIA
IIIB
IIIC
IV
99	AJCC clinical TNM stage group is unknown: no clinical manoeuvres have been used; unknown if clinical manoeuvres have been used.
RRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL48, TCOR1, TCOR19, TCOR20, TCOR21, TCOR24

Revision (T48)

Year	Description
Not applicable	Not applicable

T49 – AJCC pathologic TNM stage group

Acronym: TAJCCPATHSG

Description: The site-specific code identifying the anatomic extent of disease based on the pathologic T, N and M elements as recorded in TNM Pathologic T, N and M fields.

Effective: Reference year 2003 and onwards.

Length: 4

Specific values & meaning (T49)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
X	All reasonable pathologic manoeuvres have been used, but Pathologic TNM values do not lead to a certain, specific stage group.
0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
I
II
IIA
IIB
III
IIIA
IIIB
IIIC
IV
99	AJCC pathologic TNM stage group is unknown: no pathologic manoeuvres have been used; unknown if pathologic manoeuvres have been used.
RRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL49, TCOR1, TCOR19, TCOR20, TCOR22, TCOR24

Revision (T49)

Year	Description
Not applicable	Not applicable

T50 – AJCC TNM stage group

Acronym: TAJCCSG

Description: The site-specific code identifying the stage group when Clinical / Pathologic T, N, M values are incomplete and do not lead to a Clinical / Pathologic stage group.

Effective: Reference year 2003 and onwards.

Length: 4

Specific values & meaning (T50)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope).
0	Site-specific meaning See AJCC Cancer staging manual, sixth edition for exact meaning.
I
II
IIA
IIB
III
IIIA
IIIB
IIIC
IV
99	AJCC TNM stage group is unknown.
RRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL50, TCOR1, TCOR19, TCOR20, TCOR23, TCOR24

Revision (T50)

Year	Description
Not applicable	Not applicable

T51 – AJCC edition number

Acronym: TAJCCEDNUM

Description: Identifies the edition of the Cancer Staging Manual used to stage the case. TNM codes have changed over time and conversion is not always possible. Therefore, a case-specific indicator is needed to allow grouping of cases for comparison.

Effective: Reference year 2003 and onwards.

Length: 2

Specific values & meaning (T51)

Value	Meaning
[Blank]	Tumour outside the CCR AJCC TNM staging scope (see section 1.1.2.3 CCR AJCC TNM staging scope)
00	Not staged (AJCC/UICC staging scheme applies however site not staged)
01	AJCC sixth edition
02	AJCC seventh edition
11	International union against cancer (UICC) sixth edition
12	International union against cancer (UICC) seventh edition
98	AJCC staged, but the edition is unknown
99	UICC staged, but the edition is unknown
RR	Reported data rejected by CCR system (For Statistics Canada use only)

Related edits: TVAL51, TCOR1, TCOR19, TCOR24

Revision (T51)

Year	Description
2004	Value '88' (Not applicable: cases that do not have an AJCC/UICC staging scheme) has been removed since every tumour included in CCR AJCC TNM staging scope(see section 1.1.2.3) has an AJCC staging scheme.

T52 – CS Version 1^st

Acronym: TCSFVER

Description: Indicates the number of the version used to initially code Collaborative staging fields. The data item should be entered at the time the CS fields are first coded and the algorithm first applied. If the calculation algorithm is not called at the time of the initial abstracting, the CS Version 1st could also be entered manually by the abstractor.

Effective: Reference year 2004 and onwards.

Length: 6

Specific values & meaning (T52)

Value	Meaning
[Blank]	Tumour outside the CCR collaborative staging scope (see section 1.1.2.2 CCR collaborative staging scope).
[others]	Refer to Appendix A (Part III – CCR System Guide) – Core reference tables – Eligible CS Version 1st codes for meaning.
999999	Not staged if all other CS fields are '9' filled; otherwise see the recommended version of the Collaborative Staging Manual and Coding Instructions (see section 1.1.2.2) for exact meaning.
RRRRRR	Reported data rejected by CCR system. (For Statistics Canada use only)

Related edits: TVAL27, TVAL28, TVAL29, TVAL30, TVAL31, TVAL32, TVAL33, TVAL34, TVAL35, TVAL36, TVAL37, TVAL38, TVAL39, TVAL40, TVAL41, TVAL52, TCOR1, TCOR18

Revision (T52)

Year	Description
2007	New field added: Was formerly TD19 – CS Version 1st.

T53– Ambiguous terminology diagnosis

Acronym: TAMBIGTERM

Description: Identifies all cases, including death certificate only and autopsy only, for which an ambiguous term is used to establish a cancer diagnosis (for example, to determine whether or not the case is reportable). Ambiguous terminology may originate from any source document, such as pathology report, radiology report, or from a clinical report. This data item is used only when ambiguous terminology is used to establish diagnosis. It is not used when ambiguous terminology is used to clarify a primary site, specific histology, histologic group, or stage of disease. It is not used if there is any conclusive statement of a cancer diagnosis in the medical record.

This data item will identify specific primary sites where the ambiguous terminology is commonly used to describe or establish a cancer diagnosis.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 335-337) for more details on definitions, time frames, coding instructions and examples.

Refer to the CCR Appendix I (Part II – CCR System Guide): Guidelines for Ambiguous Terms, as referenced in T12 (date of diagnosis).

Effective: Reference year 2008 and onwards.

Length: 1

Specific values & meaning (T53)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Conclusive terminology of cancer diagnosis in medical record
0	Conclusive terminology within 60 days of original diagnosis
1	Ambiguous terminology only (includes all diagnostic methods except cytology)
2	Ambiguous terminology followed by conclusive terminology (more than 60 days after initial diagnosis)
9	Unknown terminology (no information about ambiguous terminology)

Related edits: TVAL53, TCOR1, TCOR26, TCOR29

Revision (T53)

Year	Description
2008	New variable must be reported

T54– Date of conclusive diagnosis

Acronym: TDATCONCLUSDIAG

Description: The date when a conclusive cancer diagnosis (definite statement of malignancy) is made following an initial diagnosis that was based only on ambiguous terminology. Change the code for data item "Ambiguous terminology diagnosis" from a 1 to a 2 and enter the date that the malignancy was described clearly and definitively in "Date of conclusive diagnosis". The date of the conclusive diagnosis must be greater than 60 days following the initial (ambiguous terminology only) diagnosis.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 338) for more details on definitions, time frames and examples.

Effective: Reference year 2008 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T54)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Cancer diagnosis based initially on conclusive terminology
[2008-xxxx]	Year of conclusive diagnosis (2008 to current reference year)
0000	Accessioned based on ambiguous terminology only (Code 1 in data item Ambiguous terminology diagnosis)
8888	Not applicable, initial diagnosis made by conclusive diagnosis within 60 days of original diagnosis (Code 0 in data item Ambiguous terminology diagnosis)
9999	Year unknown for conclusive diagnosis made after Ambiguous terminology diagnosis

MM (T54)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Cancer diagnosis based initially on conclusive terminology
[01-12]	Month of conclusive diagnosis (January – December)
00	Accessioned based on Ambiguous terminology diagnosis only (Code 1 in data item Ambiguous terminology diagnosis)
88	Not applicable, initial diagnosis made by conclusive diagnosis within 60 days of original diagnosis (Code 0 in data item Ambiguous terminology diagnosis)
99	Month unknown for conclusive diagnosis made after Ambiguous terminology diagnosis

DD (T54)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Cancer diagnosis based initially on conclusive terminology
[01-31]	Day of diagnosis
00	Accessioned based on ambiguous terminology diagnosis only (Code 1 in data item Ambiguous terminology diagnosis)
88	Not applicable, initial diagnosis made by conclusive diagnosis within 60 days of original diagnosis (Code 0 in data item Ambiguous terminology diagnosis)
99	Day unknown for conclusive diagnosis made after Ambiguous terminology diagnosis

Related edits: TVAL54, TCOR1, TCOR26, TCOR29, TCOR30.

Revision (T54)

Year	Description
2008	New variable must be reported

T55– Type of multiple tumours reported as one primary

Acronym: TMULTTUMONEPRIM

Description: This data item is used to identify the type of multiple tumours in cases with multiple tumours that are abstracted and reported as a single primary using the SEER multiple primary rules.

Multiple tumours may individually exhibit in situ, invasive, or a combination of in situ and invasive behaviours.

Multiple intracranial and central nervous system tumours may individually exhibit benign, borderline, or a combination of these behaviours.

Multiple tumours found in the same organ or in a single primary site may occur at the time of initial diagnosis or later.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 342-343) for more details on definitions, time frames and examples.

Effective: Reference year 2008 and onwards.

Related edits: TVAL55, TCOR1, TCOR31, TCOR32, TCOR33, TCOR34, TCOR35

Revision (T55)

Year	Description
2008	New variable must be reported

Specific values & meaning (T55)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Variable not used
00	Single tumour
10	Multiple benign (intracranial and CNS sites only)
11	Multiple borderline
12	Benign (intracranial and CNS sites only) and borderline
20	Multiple in situ
30	In situ and invasive
31	Polyp and adenocarcinoma
32	Familial Adenomatous Polyposis (FAP) with carcinoma
40	Multiple invasive or Two or more invasive tumours plus one or more in situ tumours
80	Unknown in situ or invasive
88	Not Applicable for this site
99	Unknown

T56– Date of multiple tumours

Acronym: TDATMULT

Description: This data item is used to identify the year, month and day the patient is diagnosed with multiple tumours reported as a single primary. Use the SEER multiple primary rules for that specific site to determine whether the tumours are a single primary or multiple primaries.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 341) for more details on definitions, time frames and examples.

Effective: Reference year 2008 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Specific values & meaning
YYYY (T56)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Variable not used
[2008-xxxx]	Year of Date of multiple tumours (2008 to current reference year)
0000	Single tumour
8888	Information on multiple tumours not applicable for this site
9999	Year of Date of multiple tumours is unknown

MM (T56)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Variable not used
[01-12]	Month of Date of multiple tumours (January – December)
00	Single tumour
88	Information on multiple tumours not applicable for this site
99	Month of Date of multiple tumours is unknown

DD (T56)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Variable not used
[01-31]	Day of Date of multiple tumours
00	Single tumour
88	Information on multiple tumours not applicable for this site
99	Day of Date of multiple tumours is unknown

Related edits: TVAL56, TCOR1, TCOR33, TCOR34, TCOR35

Revision (T56)

Year	Description
2008	New variable must be reported

T57– Multiplicity counter

Acronym: TMULTCOUNT

Description: This data item is used to count the number of tumours (multiplicity) that are reported as a single primary, when present at the time of diagnosis. Do not count metastatic tumours.

Refer to the SEER Multiple Primary and Histology Coding Rules Manual (page 339-340) for more details on definitions, time frames and examples.

Once a case has documented multiple tumours in the Multiplicity Counter, do not update the counter. Do not continue to add subsequent lesions.

Example:

• 2 tumours at diagnosis; enter 02
• If a third tumour is diagnosed later which is considered part of the same primary, do not update Multiplicity Counter to 03

Examples of when to use code "88":

• Essential Thrombocythemia (ICD-O-3 Histology of 9962/3)
• All lymphomas, leukemias and immunoproliferative (ICD-O-3 Histology 9590-9989)
• Multiple myeloma (ICD-O-3 Histology 9732)
• Myelodysplastic syndromes (ICD-O-3 Histology 9980-9989)
• EXCEPT ICD-O-3 Histology 9731, 9734, 9740, 9750, 9755, 9756, 9757, 9758, 9930

Effective: Reference year 2008 and onwards.

Length: 2

Refer to coding manual for detailed coding instructions.

Specific values & meaning (T57)

Value	Meaning
[Blank]	For cases diagnosed prior to 2008, leave this file blank –or– Information on multiple tumours not collected
01-87	Number of tumours present
88	Information on multiple tumours not applicable to this site (see examples above)
99	Multiple tumours present, unknown how many; unknown if single or multiple tumours

Related edits: TVAL57, TCOR1, TCOR33, TCOR34, TCOR35

Revision (T57)

Year	Description
2008	New variable must be reported

2.4 Derived tumour variables

The derived tumour variables are variables related to the tumour and copied/derived/calculated by the CCR system through various processes such as data loading, record linkage and death clearance. Table 13 lists all the derived tumour variables; the following pages describe these variables in more detail.

For convenience, variables are presented in order by variable number. The reader can easily find the page corresponding to any variable by looking for the variable number in the title. For example, age at diagnosis is described on page TD3 – Age at diagnosis.

Table 13 List of the derived tumour variables

Variable N°	Variable	Acronym
TD1	Processing date – Tumour record	TDCCRDATPROC
TD2	Sequence number	TDCCRSEQNUM
TD3	Age at diagnosis	TDCCRAGEDIAG
TD4	Age group at diagnosis	TDCCRAGEGRP
TD5	Survival interval	TDDCSURVINT
TD6	Survival censor	TDDCCENSOR
TD7	Derived AJCC T	TDCSAJCCT
TD8	Derived AJCC N	TDCSAJCCN
TD9	Derived AJCC M	TDCSAJCCM
TD10	Derived AJCC T descriptor	TDCSAJCCTDESC
TD11	Derived AJCC N descriptor	TDCSAJCCNDESC
TD12	Derived AJCC M descriptor	TDCSAJCCMDESC
TD13	Derived AJCC stage group	TDCSAJCCSG
TD14	Derived AJCC flag	TDCSAJCCF
TD15	Derived SS1977	TDCSSS1977
TD16	Derived SS1977 flag	TDCSSS1977F
TD17	Derived SS2000	TDCSSS2000
TD18	Derived SS2000 flag	TDCSSS2000F
TD19	CS version latest	TDCSLVER
TD20	Filler	Not applicable

TD1 – Processing date – tumour record

Acronym: TDCCRDATPROC

Description: The date any action was last taken on the tumour record by Statistics Canada.

Effective: Reference year 1992 and onwards.

Length: 8

Format: YYYYMMDD where YYYY stands for the year, MM stands for the month and DD stands for the day.

Used by (TD1)

Process	Read	Write
Data Loading – posting	No	Yes*
Internal Record Linkage	No	Yes*
Death Clearance	No	Yes*
Tabulation Master File	Yes	No

* See corresponding section for calculation details.

Specific values & meaning
YYYY (TD1)

Value	Meaning
[0000-9999]	Year of the last action

MM (TD1)

Value	Meaning
[01-12]	Month of the last action (January – December)

DD (TD1)

Value	Meaning
[01-31]	Day of the last action

Revision (TD1)

Year	Description
2004	Acronym changed: Formerly known as TDATPROC

TD2 – Sequence number

Acronym: TDCCRSEQNUM

Description: A chronologic sequence number of multiple primaries for this patient since 1992.

This number does not represent an absolute sequence order of multiple primaries for this patient, as it does not consider any primary cancers that may have been diagnosed for this patient prior to 1992.

Note: The sequence number may change depending on the Multiple primary rules used (CCR or IARC). As of 2007 the CCR has adopted SEER rules.

Effective: Reference year 1992 and onwards.

Length: 2

Used by (TD2)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD2)

Value	Meaning
[01-99]	Sequence number
**	Sequence number higher than 99

Revision (TD2)

Year	Description
2004	Acronym changed: Formerly known as TSEQNUM

TD3 – Age at diagnosis

Acronym: TDCCRAGEDIAG

Description: The patient's age in years at the time of diagnosis of the tumour.

Effective: Reference year 1992 and onwards.

Length: 3

Format: NNN (fixed-Length, zero-left-padded)

Used by (TD3)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD3)

Value	Meaning
[000-998]	Age
999	Age unknown (assigned when Date of birth is unknown)

Revision (TD3)

Year	Description
2004	Acronym changed: Formerly known as AGEDIAG

TD4 – Age group at diagnosis

Acronym: TDCCRAGEGRP

Description: A code that represents the range of years in which the Age at diagnosis falls.

Effective: Reference year 1992 and onwards.

Length: 2

Used by (TD4)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

*See corresponding section for calculation details.

Specific values & meaning (TD4)

Value	Meaning
1	<1
2	1 to 4
3	5 to 9
4	10 to 14
5	15 to 19
6	20 to 24
7	25 to 29
8	30 to 34
9	35 to 39
10	40 to 44
11	45 to 49
12	50 to 54
13	55 to 59
14	60 to 64
15	65 to 69
16	70 to 74
17	75 to 79
18	80 to 84
19	85 to 998
20	999 (Age unknown)

Revision (TD4)

Year	Description
2004	Acronym changed: Formerly known as AGEGRP

TD5 – Survival interval

Acronym: TDDCSURVINT

Description: The number of days between the Date of diagnosis and the first of the following events: Death clearance cut off date or Date of death.

Effective: Reference year 1992 and onwards.

Length: 5

Used by (TD5)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD5)

Value	Meaning
[0-99997]	Number of days.
99998	Survival interval cannot be computed: Death Certificate Only (DCO) records, corresponding patient record never underwent Death clearance process or Date of diagnosis is after the Death clearance cut-off date.
99999	Survival interval cannot be computed: Corresponding patient Date of death is unknown.

Revision (TD5)

Year	Description
2007	Specific values & meaning: The survival interval for DCO cases cannot be computed and is subsequently recorded as '99998'. Text revised for clarification.
2004	Acronym changed: Formerly known as SURVINT.

TD6 – Survival censor

Acronym: TDDCCENSOR

Description: A code indicating whether the Survival interval was computed using the Date of death or the Death clearance cut-off date.

Effective: Reference year 1992 and onwards.

Length: 1

Used by (TD6)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD6)

Value	Meaning
0	Survival interval was not computed.
1	Survival interval was computed using Date of death.
2	Survival interval was computed using Death clearance cut-off date.

Revision (TD6)

Year	Description
2004	Acronym changed: Formerly known as CENSOR.

TD7 – Derived AJCC T

Acronym: TDCSAJCCT

Description: A code that represents the AJCC 'T' component that is derived from CS coded fields using the CS algorithm. Derived AJCC T can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD7)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD7)

Value	Display string*
99	TX
00	T0
01	Ta
05	Tis
06	Tispu
07	Tispd
10	T1
11	T1mic
12	T1a
13	T1a1
14	T1a2
15	T1b
16	T1b1
17	T1b2
18	T1c
19	T1NOS
20	T2
29	T2NOS
21	T2a
22	T2b
23	T2c
30	T3
39	T3NOS
31	T3a
32	T3b
33	T3c
40	T4
49	T4NOS
41	T4a
42	T4b
43	T4c
44	T4d
88	Not applicable
Blank	CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD7)

Year	Description
Not applicable	Not applicable

TD8 – Derived AJCC N

Acronym: TDCSAJCCN

Description: A code that represents the AJCC 'N' component that is derived from CS coded fields using the CS algorithm. Derived AJCC N can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD8)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD8)

Value	Display string*
99	NX
00	N0
09	N0NOS
01	N0(i-)
02	N0(i+)
03	N0(mol-)
04	N0(mol+)
10	N1
19	N1NOS
11	N1a
12	N1b
13	N1c
18	N1mi
20	N2
29	N2NOS
21	N2a
22	N2b
23	N2c
30	N3
39	N3NOS
31	N3a
32	N3b
33	N3c
88	Not applicable
Blank	CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD8)

Year	Description
Not applicable	Not applicable

TD9 – Derived AJCC M

Acronym: TDCSAJCCM

Description: A code that represents the AJCC 'M' component that is derived from CS coded fields using the CS algorithm. Derived AJCC M can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD9)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD9)

Value	Display String*
99	MX
00	M0
10	M1
11	M1a
12	M1b
13	M1c
19	M1NOS
88	Not applicable
Blank	CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD9)

Year	Description
Not applicable	Not applicable

TD10 – Derived AJCC T descriptor

Acronym: TDCSAJCCTDESC

Description: A code that represents the AJCC 'T descriptor' component that is derived from CS coded fields using the CS algorithm. Derived AJCC T descriptor can be used in analysis to differentiate the timing of staging with respect to the treatment process.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD10)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD10)

Value	Meaning
c	Clinical stage
p	Pathologic stage
a	Autopsy stage
y	Cases in which staging classification is performed during or following initial multimodality therapy. Surgical resection performed after pre-surgical systemic treatment or radiation; tumour size/extension based on pathologic evidence.
N	Not applicable
Blank	CS algorithm was not run

Revision (TD10)

Year	Description
Not applicable	Not applicable

TD11 – Derived AJCC N descriptor

Acronym: TDCSAJCCNDESC

Description: A code that represents the AJCC 'N descriptor' component that is derived from CS coded fields using the CS algorithm. Derived AJCC N descriptor can be used in analysis to differentiate the timing of staging with respect to the treatment process.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD11)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD11)

Value	Meaning
c	Clinical stage
p	Pathologic stage
a	Autopsy stage
y	Cases in which staging classification is performed during or following initial multimodality therapy. Lymph nodes removed for examination after pre-surgical systemic treatment or radiation and lymph node evaluation based on pathologic evidence.
N	Not applicable
Blank	CS algorithm was not run

Revision (TD11)

Year	Description
Not applicable	Not applicable

TD12 – Derived AJCC M descriptor

Acronym: TDCSAJCCMDESC

Description: A code that represents the AJCC 'M descriptor' component that is derived from coded fields using the CS algorithm. Derived AJCC M descriptor is used in analysis to differentiate the timing of staging with respect to the treatment process.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD12)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD12)

Value	Meaning
c	Clinical stage
p	Pathologic stage
a	Autopsy stage
y	Cases in which staging classification is performed during or following initial multimodality therapy. Pathologic examination of metastatic tissue performed after pre-surgical systemic treatment or radiation and extension based on pathologic evidence.
N	Not applicable
Blank	CS algorithm was not run

Revision (TD12)

Year	Description
Not applicable	Not applicable

TD13 – Derived AJCC stage group

Acronym: TDCSAJCCSG

Description: A code that represents the AJCC 'stage group' component that is derived from CS coded fields using the CS algorithm. Derived AJCC stage group can be used to evaluate disease spread at diagnosis, plan and track treatment patterns, and analyze outcomes.

Effective: Reference year 2004 and onwards.

Length: 2

Used by (TD13)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD13)

Value	Display string*
00	0
01	0a
02	0is
10	I
11	INOS
12	IA
13	IA1
14	IA2
15	IB
16	IB1
17	IB2
18	IC
19	IS
23	ISA
24	ISB
20	IEA
21	IEB
22	IE
30	II
31	IINOS
32	IIA
33	IIB
34	IIC
35	IIEA
36	IIEB
37	IIE
38	IISA
39	IISB
40	IIS
41	IIESA
42	IIESB
43	IIES
50	III
51	IIINOS
52	IIIA
53	IIIB
54	IIIC
55	IIIEA
56	IIIEB
57	IIIE
58	IIISA
59	IIISB
60	IIIS
61	IIIESA
62	IIIESB
63	IIIES
70	IV
71	IVNOS
72	IVA
73	IVB
74	IVC
88	Not applicable
90	OCCULT
99	UNK
Blank	CS algorithm was not run

* The meaning of the Display strings is explained for each site in the AJCC Cancer staging manual, sixth edition.

Revision (TD13)

Year	Description
Not applicable	Not applicable

TD14 – Derived AJCC flag

Acronym: TDCSAJCCF

Description: A code that indicates whether AJCC stage group was coded directly or derived from collaborative staging.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD14)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD14)

Value	Meaning
1	AJCC 6th edition derived from Collaborative Staging Manual and Coding Instructions, version 01.04.01
2	Not valid for CCR
Blank	CS algorithm was not run

Revision (TD14)

Year	Description
Not applicable	Not applicable

TD15 – Derived SS1977

Acronym: TDCSSS1977

Description: A code that represents the SEER Summary Stage 1977 component (anatomic extent of disease at diagnosis for cases diagnosed prior to January 1^st, 2001) that is derived from CS coded fields using the CS algorithm.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD15)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD15)

Value	Meaning
0	IS (In Situ)
1	L (Localized)
2	RE (Regional, direct extension)
3	RN (Regional, lymph nodes only)
4	RE+RN (Regional, extension and nodes)
5	RNOS (Regional, NOS)
7	D (Distant)
8	NA (Not applicable)
9	U (Unknown/Unstaged)
Blank	CSalgorithm was not run

Revision (TD15)

Year	Description
Not applicable	Not applicable

TD16 – Derived SS1977 flag

Acronym: TDCSSS1977F

Description: A code that indicates whether Derived SS1977 was derived from collaborative staging.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD16)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD16)

Value	Meaning
1	SS1977 derived from Collaborative Staging Manual and Coding Instructions, version 01.04.01.
2	Not valid for CCR.
Blank	CS algorithm was not run.

Revision (TD16)

Year	Description
Not applicable	Not applicable

TD17 – Derived SS2000

Acronym: TDCSSS2000

Description: A code that represents the SEER Summary Stage 2000 component (anatomic extent of disease at diagnosis for cases diagnosed on or after January 1^st, 2001) that is derived from CS coded fields using the CS algorithm.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD17)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD17)

Value	Meaning
0	IS (In Situ)
1	L (Localized)
2	RE (Regional, direct extension)
3	RN (Regional, lymph nodes only)
4	RE+RN (Regional, extension and nodes)
5	RNOS (Regional, NOS)
7	D (Distant)
8	NA (Not applicable)
9	U (Unknown/Unstaged)
Blank	CS algorithm was not run

Revision (TD17)

Year	Description
Not applicable	Not applicable

TD18 – Derived SS2000 flag

Acronym: TDCSSS2000F

Description: A code that indicates whether Derived SS2000 was derived from collaborative staging.

Effective: Reference year 2004 and onwards.

Length: 1

Used by (TD18)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD18)

Value	Meaning
1	SS2000 derived from Collaborative Staging Manual and Coding Instructions, version 01.04.01.
2	Not valid for CCR.
Blank	CS algorithm was not run.

Revision (TD18)

Year	Description
Not applicable	Not applicable

TD19 – CS version latest

Acronym: TDCSLVER

Description: The version of the collaborative staging used most recently to derive the CS output fields at the CCR. This data item is recorded the first time the CS output fields are derived and should be updated each time the CS derived items are re-computed. The CS version number is returned as part of the output of the CS algorithm. The returned value from the program should be automatically stored as CS Version Latest. This item should not be updated manually.

Effective: Reference year 2004 and onwards.

Length: 6

Used by (TD19)

Process	Read	Write
Data loading – posting	No	No
Internal record linkage	No	No
Death clearance	No	No
Tabulation master file	Yes	Yes*

* See corresponding section for calculation details.

Specific values & meaning (TD19)

Value	Meaning
[000000-999999]	Version number
Blank	CS algorithm was not run or field not implemented

Revision (TD19)

Year	Description
2007	CS version latest (Formerly known as TD20 – CS version latest) replaces TD19. Name: Formerly known as TD19 – CS Version 1st.  Description: Data concerning CS version 1st is now collected as a tumour input variable as T52 – CS Version 1st.

TD20 –Filler

Acronym: Not applicable

Description: Filler: free space reserved for future requirement implementation.

This field will not be processed or returned by the CCR System.

Effective: Reference year 2006 and onwards.

Length: 6

Used by: Not applicable

Specific values & meaning: Not applicable

Revision (TD20)

Year	Description
2007	Name: Formerly known as TD20 – CS version latest. Description: Field now converted to filler. Data concerning CS version latest is now derived as TD19 – CS version latest.